{
  "meta": {
    "title": "00029_Late_Night_Pyq_Pyt_Marathon_-_28",
    "url": "https://brainandscalpel.vercel.app/00029-late-night-pyq-pyt-marathon-28-630733a7.html",
    "scrapedAt": "2025-11-29T17:24:42.033Z"
  },
  "questions": [
    {
      "id": 2160,
      "choices": [
        {
          "id": 8629,
          "text": "<p>ATGGAC-TACGTG</p>"
        },
        {
          "id": 8630,
          "text": "<p>GATATC- CTATAG</p>"
        },
        {
          "id": 8631,
          "text": "<p>TAGATA-ATCTAT</p>"
        },
        {
          "id": 8632,
          "text": "<p>AATATA-TATAAT</p>"
        }
      ],
      "text": "<p>Which of the following site does the restriction enzyme act when RFLP is used in-order to identify the five different species of staphylococci in a surgical ICU?&nbsp;(AIIMS Nov 2017)</p>",
      "unique_key": "Q9600607",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601153,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B)&nbsp;GATATC- CTATAG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Restriction Fragment Length Polymorphism (RFLP) is a difference in homologous DNA sequences that can be detected by the presence of fragments of different lengths after digestion of the DNA samples in question with specific restriction endonucleases.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Restriction endonucleases have specific recognition sites where they cut the DNA. These enzymes recognize specific sequence with palindrome arrangement. These are also called inverted repeat sequences, which means the nucleotide sequence in 5′ to 3′ direction is the same in both strands.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B</strong>. is a palindromic sequence, hence the correct the answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-171110.jpg\" alt=\"\" width=\"1000\" height=\"466\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A: ATGGAC – TACGTG&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">This is <strong>not a palindrome</strong>.</span></li><li><span style=\"font-size:16px;\">5'-ATGGAC</span><br><span style=\"font-size:16px;\">3'-TACCTG&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C: TAGATA – ATCTAT&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Not a palindrome.</span></li><li><span style=\"font-size:16px;\">5'-TAGATA</span><br><span style=\"font-size:16px;\">3'-ATCTAT</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D: AATATA – TATAAT&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">5'-AATATA</span><br><span style=\"font-size:16px;\">3'-TATAAT</span></li><li><span style=\"font-size:16px;\">Not a palindrome either.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In RFLP, restriction enzymes recognize and cut at palindromic sequences in DNA. The palindromic sequence GATATC-CTATAG is a correct recognition site for these enzymes, making it crucial for identifying different species, such as staphylococci in a surgical ICU.</span></p>",
      "correct_choice_id": 8630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32674,
      "choices": [
        {
          "id": 130546,
          "text": "<p><span style=\"font-size:12.0pt;\">Cephalin</span></p>"
        },
        {
          "id": 130547,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelin</span></p>"
        },
        {
          "id": 130548,
          "text": "<p><span style=\"font-size:12.0pt;\">Lecithin</span></p>"
        },
        {
          "id": 130549,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiolipin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Respiratory distress syndrome is caused by the deficiency of?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q6572447",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601154,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Lecithin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Specifically phosphatidylcholine, is a major component of pulmonary surfactant. Surfactant plays a crucial role in reducing surface tension in the alveoli of the lungs, preventing their collapse. A deficiency in lecithin can contribute to respiratory distress syndrome, especially in premature infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cephalin:&nbsp;</strong>Cephalin is a type of phospholipid, and while it is present in cell membranes, it is not a major component of pulmonary surfactant and is not directly associated with respiratory distress syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sphingomyelin:&nbsp;</strong>Sphingomyelin is another type of phospholipid found in cell membranes. The deficiency to recycle this lipid due to defective lysosomal enzyme sphingomyelinase cause sphingolipidoses also known as Niemann Pick disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cardiolipin:&nbsp;</strong>Cardiolipin is a phospholipid found in the inner mitochondrial membrane and bacterial membranes. The disease associated with cardiolipins are anti-phospholipid syndrome and Barth syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">RDS is a common condition in premature infants due to inadequate surfactant production, particularly the deficiency of lecithin. The educational objective is to understand the etiology of RDS and its association with surfactant components, specifically lecithin. This knowledge is crucial for healthcare professionals involved in the care of neonates, as RDS can have serious respiratory consequences in premature infants and requires appropriate management and support.</span></p>",
      "correct_choice_id": 130548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55614,
      "choices": [
        {
          "id": 221901,
          "text": "<p><span style=\"font-size:12.0pt;\">Frameshift mutation of coding gene</span></p>"
        },
        {
          "id": 221902,
          "text": "<p><span style=\"font-size:12.0pt;\">Addition of another normal gene</span></p>"
        },
        {
          "id": 221903,
          "text": "<p><span style=\"font-size:12.0pt;\">Deletion of the mutant gene</span></p>"
        },
        {
          "id": 221904,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation of tRNA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which type of mutation results in the reversal to the wild type of phenotype when the mutant gene is suppressed?&nbsp;(INICET MAY 2024)</span></p>",
      "unique_key": "Q9184502",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601155,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mutation of tRNA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is <strong>Mutation of tRNA</strong>. A suppressor mutation, specifically a <strong>tRNA mutation</strong>, can reverse the effect of an earlier mutation that produced a premature stop codon. In this scenario, the tRNA undergoes a mutation that allows it to recognize the stop codon (UAA in this case) as if it were a normal codon (e.g., serine's codon UCA). This suppressor tRNA can then insert an amino acid at the site of the stop codon, allowing protein synthesis to continue. This compensates for the earlier mutation that would have led to a truncated, non-functional protein, thereby restoring the wild-type phenotype.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/whatsapp-image-2024-08-31-at-12858-pm.jpeg\" alt=\"\" width=\"400\" height=\"313\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;<img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/31/screenshot-2024-08-31-170152.png\" alt=\"\" width=\"400\" height=\"274\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Frameshift mutation of coding gene</strong>: This type of mutation typically disrupts the reading frame of the gene, leading to widespread changes in the amino acid sequence from the point of mutation onward. It usually results in a non-functional protein and does not suppress the effects of another mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Addition of another normal gene</strong>: While adding a normal gene might help correct a phenotype by introducing a functional version of the gene, it does not qualify as a suppressor mutation. This option does not specifically address the reversal of a mutation at the molecular level in the same way as tRNA mutation does.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Deletion of the mutant gene</strong>: Deleting the mutant gene would remove the mutation but would not revert the phenotype to wild type by itself. It eliminates the gene's effect entirely rather than compensating for the mutation within the gene or another gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Suppressor mutations, particularly those in tRNA, can reverse the effects of a previous mutation by allowing protein synthesis to continue even when a premature stop codon is present, thereby restoring the normal (wild-type) phenotype.</span></p>",
      "correct_choice_id": 221904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1907,
      "choices": [
        {
          "id": 7621,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Acetyl CoA</span></p>"
        },
        {
          "id": 7622,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Oxaloacetate</span></p>"
        },
        {
          "id": 7623,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Acetaldehyde</span></p>"
        },
        {
          "id": 7624,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Lactic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the anaplerotic reaction among the following? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q3957900",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601156,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Conversion of pyruvate to Oxaloacetate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anaplerotic reactions are “filling up” reactions or “influx” reactions or “replenishing” reactions which supply 4-carbon units to the TCA cycle</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The important anaplerotic reactions are:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Pyruvate to oxaloacetate by <strong>pyruvate carboxylase</strong> enzyme. It needs ATP.</span></li><li><span style=\"font-size:12.0pt;\">Glutamate is transaminated to alpha keto glutarate; and aspartate to oxaloacetate.</span></li><li><span style=\"font-size:12.0pt;\">Pyruvate can be carboxylated to malate by <strong>NADP+ dependent malic enzyme.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The citric acid cycle acts as a source of precursors of biosynthetic pathways, e.g., heme is synthesized from succinyl CoA and aspartate from oxaloacetate. To counterbalance such losses, and <strong>to keep the concentrations of the 4-carbon units in the cell, anaplerotic reactions are essential</strong>. This is called anaplerotic role of TCA cycle (Greek word, ana = up; plerotikos = to fill)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Conversion of pyruvate to Acetyl CoA:&nbsp;</strong>This is not an anaplerotic reaction; it is a part of the link between glycolysis and the TCA cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Conversion of pyruvate to Acetaldehyde:&nbsp;</strong>This reaction is part of ethanol fermentation, not an anaplerotic reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Conversion of pyruvate to Lactic acid:&nbsp;</strong>This is part of anaerobic glycolysis (fermentation), not an anaplerotic reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anaplerotic reactions, such as the conversion of pyruvate to oxaloacetate, are crucial for maintaining the levels of TCA cycle intermediates, enabling the cycle to function efficiently and support biosynthetic demands.</span></p>",
      "correct_choice_id": 7622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57695,
      "choices": [
        {
          "id": 230149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">DNA replication</span></span></span></p>"
        },
        {
          "id": 230150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Fatty acid synthesis</span></span></span></p>"
        },
        {
          "id": 230151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Protein degradation</span></span></span></p>"
        },
        {
          "id": 230152,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogenolysis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A biochemistry student is studying the various roles of NADPH in cellular metabolism. The student learns that NADPH plays a critical role in providing reducing power for specific biosynthetic reactions. In which of the following biological processes is NADPH primarily utilized?</span></span></span></p>",
      "unique_key": "Q4754243",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601157,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: B. Fatty acid synthesis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">NADPH is crucial in fatty acid synthesis, where it acts as a reducing agent that provides the necessary electrons to convert acetyl-CoA into long-chain fatty acids. NADPH donates hydrogen atoms during the reduction steps required to build carbon chains, particularly in the enzymatic actions of ketoacyl-ACP reductase and enoyl-ACP reductase during de novo fatty acid synthesis. The reducing power of NADPH is essential for the synthesis of fatty acids, as it helps convert precursors into fully formed fatty acid molecules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. DNA replication:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> DNA replication primarily involves the synthesis of DNA using nucleotides and enzymes such as DNA polymerase. NADPH does not play a direct role in this process, as the reactions are driven by nucleotide triphosphates rather than reduction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Protein degradation:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Protein degradation involves the breakdown of proteins into amino acids, mainly facilitated by proteolytic enzymes. This process does not require NADPH, as it involves hydrolysis rather than reduction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Glycogenolysis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Glycogenolysis is the breakdown of glycogen into glucose-1-phosphate and glucose. This process is catalyzed by glycogen phosphorylase and other enzymes, and does not involve NADPH, as it is not a reducing process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">NADPH is primarily used as a reducing agent in biosynthetic processes, such as fatty acid synthesis, cholesterol synthesis, and the detoxification of reactive oxygen species. It is generated by pathways like the hexose monophosphate shunt and utilized in reactions requiring reduction, underscoring its importance in cellular metabolism and protection against oxidative stress. Understanding NADPH&#39;s role in metabolic pathways highlights its critical function in anabolic and protective cellular processes.</span></span></span></p>",
      "correct_choice_id": 230150,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5037,
      "choices": [
        {
          "id": 20122,
          "text": "<p><span style=\"font-size:12.0pt;\">Histone</span></p>"
        },
        {
          "id": 20123,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycoprotein</span></p>"
        },
        {
          "id": 20124,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleic acid</span></p>"
        },
        {
          "id": 20125,
          "text": "<p><span style=\"font-size:12.0pt;\">Helicases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">DNA packing is done by?</span>(NEET PG 2022)</p>",
      "unique_key": "Q8177466",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601278,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Histone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histones are proteins responsible for DNA packaging. The DNA wraps around histones, forming a structure called a nucleosome. Histones are positively charged proteins that interact with the negatively charged DNA, allowing for efficient packaging and compaction of DNA strands. This packaging is essential for the organization of DNA within the cell nucleus and its regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Glycoprotein:&nbsp;</strong>Glycoproteins are not directly involved in DNA packaging. They are molecules composed of a protein and a carbohydrate moiety. While glycoproteins have various functions in the cell, they do not play a role in the compaction and organization of DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Nucleic acid:&nbsp;</strong>DNA itself is a type of nucleic acid. DNA molecules are composed of nucleotides and serve as the genetic material of cells. DNA molecules do not package themselves; instead, they interact with histones and other proteins to undergo packaging and compaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Helicases:&nbsp;</strong>Helicases are enzymes responsible for unwinding and separating the DNA strands during processes such as DNA replication and transcription. They do not participate in DNA packaging; instead, their role is to facilitate the access of various cellular machinery to the DNA template.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Nucleosomes = DNA + Histone proteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histone proteins are rich in basic AA such as lysine and arginine, so, carry a positive charge. While DNA due to PO<sub>4</sub><sup>2-</sup> groups has large negative charge. So, in nucleosomes, DNA and histones are tightly packed due to interaction between these opposite charges.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture12.jpg\" alt=\"\" width=\"500\" height=\"258\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 351</strong></span></p>",
      "correct_choice_id": 20122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23208,
      "choices": [
        {
          "id": 92796,
          "text": "<p><span style=\"font-size:12.0pt;\">Blue, Red, Lavender, Grey</span></p>"
        },
        {
          "id": 92797,
          "text": "<p><span style=\"font-size:12.0pt;\">Lavender, Grey, Blue, Red</span></p>"
        },
        {
          "id": 92798,
          "text": "<p><span style=\"font-size:12.0pt;\">Grey, Blue, Red, Lavender</span></p>"
        },
        {
          "id": 92799,
          "text": "<p><span style=\"font-size:12.0pt;\">Red, Lavender, Grey, Blue</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the order of drawing blood sample in vials/vacutainers:&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q7692205",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601279,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A.&nbsp;Blue, Red, Lavender, Grey</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Order of Draw in Blood Collection (Vacutainer Method)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The <strong>standard order of draw</strong> is important to avoid <strong>cross-contamination of additives</strong> between tubes, which can affect lab results.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Here’s the correct order based on CLSI (Clinical and Laboratory Standards Institute) guidelines:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Blood culture bottles</strong> (if needed)</span></li><li><span style=\"font-size:16px;\"><strong>Light Blue</strong> – contains <strong>sodium citrate</strong> (for coagulation tests like PT, aPTT)</span></li><li><span style=\"font-size:16px;\"><strong>Red / Gold / SST</strong> – <strong>no additive or clot activator</strong> (for serum tests)</span></li><li><span style=\"font-size:16px;\"><strong>Green</strong> – contains <strong>heparin</strong> (for plasma chemistry)</span></li><li><span style=\"font-size:16px;\"><strong>Lavender / Pink</strong> – contains <strong>EDTA</strong> (for hematology, e.g., CBC)</span></li><li><span style=\"font-size:16px;\"><strong>Grey</strong> – contains <strong>sodium fluoride + potassium oxalate</strong> (for glucose and lactate)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">So, the correct order of drawing blood samples in vials/vacutainers is Blue, Red, Lavender, Grey.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Blue:</strong> The blue-top tube is typically used for coagulation tests that require blood to be collected in citrate anticoagulant. The citrate in the tube helps prevent blood clotting by binding calcium.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Red:</strong> The red-top tube does not contain any anticoagulant and is commonly used for collecting blood samples for various tests, including serum chemistry, blood bank, and serology. After allowing the blood to clot, it is centrifuged, and the resulting serum is used for analysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Lavender:</strong> The lavender-top tube contains EDTA (ethylenediaminetetraacetic acid) as an anticoagulant. It is used for collecting whole blood for complete blood count (CBC), blood typing, and other hematological tests. EDTA helps preserve the blood cell morphology.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Grey:</strong> The grey-top tube contains an anticoagulant called potassium oxalate or sodium fluoride. It is used primarily for glucose testing and helps preserve blood glucose levels by inhibiting glycolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The correct order of drawing blood samples in vials/vacutainers is Blue (coagulation tests), Red (serum tests), Lavender (hematology tests), and Grey (glucose tests) to ensure accurate test results and avoid cross-contamination.</span></p>",
      "correct_choice_id": 92796,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1916,
      "choices": [
        {
          "id": 7657,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle-debranching enzyme</span></p>"
        },
        {
          "id": 7658,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphoructokinase 1</span></p>"
        },
        {
          "id": 7659,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 phosphatase</span></p>"
        },
        {
          "id": 7660,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle glycogen phosphorylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An adolescent male patient presented with pain in the calf muscles on exercise. On biopsy, an excessive amount of glycogen was found to be present in the muscle. What is the most likely enzyme deficiency? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q1176197",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601280,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Muscle glycogen phosphorylase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical features described are suggestive of McArdle's disease (glycogen storage disease type V), which is caused by a deficiency of muscle glycogen phosphorylase. This enzyme deficiency leads to an inability to break down glycogen into glucose in the muscle cells, resulting in exercise intolerance, muscle pain, and accumulation of glycogen in muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Muscle-debranching enzyme:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Causes Cori's disease (glycogen storage disease type III).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Highly branched dextrin accumulates in liver and muscle, leading to fasting hypoglycemia, hepatomegaly, and myopathy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note:</strong> This enzyme is involved in the debranching process of glycogenolysis, but the primary symptoms are different from those described in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Phosphofructokinase 1:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Causes Tarui's disease (glycogen storage disease type VII).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Exercise intolerance, muscle pain, and myoglobinuria, similar to McArdle's, but also includes hemolytic anemia due to the enzyme's role in glycolysis in red blood cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note:</strong> This enzyme is involved in glycolysis, not directly in glycogen metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Glucose 6 phosphatase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Causes Von Gierke's disease (glycogen storage disease type Ia).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong> Fasting hypoglycemia, hepatomegaly, hyperuricemia, and lactic acidosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note:</strong> This enzyme deficiency affects the liver's ability to release glucose, but not directly linked to muscle symptoms described in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/01.jpg\" alt=\"\" width=\"1000\" height=\"1261\"></p>",
      "correct_choice_id": 7660,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32736,
      "choices": [
        {
          "id": 130794,
          "text": "<p><span style=\"font-size:12pt;\">E. coli</span></p>"
        },
        {
          "id": 130795,
          "text": "<p><span style=\"font-size:12pt;\">Mitochondrial DNA of human</span></p>"
        },
        {
          "id": 130796,
          "text": "<p><span style=\"font-size:12pt;\">HIV</span></p>"
        },
        {
          "id": 130797,
          "text": "<p><span style=\"font-size:12pt;\">Herpes virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">In which of the genetic material, Number of Adenine will not be equal to that of Thymine:</span></p>",
      "unique_key": "Q3476096",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601281,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) HIV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The questions is related to genetic material of different organisms or viruses and their base pairing rules. In DNA, adenine (A) always pairs with thymine (T), and cytosine (C) always pairs with guanine (G). However, in RNA, which is the genetic material of some viruses like HIV, thymine is replaced by uracil (U) in base pairing. So, in RNA, adenine pairs with uracil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>E. coli (Escherichia coli): </strong>E. coli is a bacterium, and its genetic material is DNA. In DNA, adenine pairs with thymine, so the number of adenine is equal to the number of thymine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong> <strong>Mitochondrial DNA of humans:</strong> Mitochondrial DNA is also composed of DNA, and in DNA, adenine pairs with thymine. Therefore, the number of adenine is equal to the number of thymine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong> <strong>Herpes virus:</strong> Herpes viruses have dsDNA as their genetic material, so adenine pairs with thymine in their DNA. Thus, the number of adenine is equal to the number of thymine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HIV (Human Immunodeficiency Virus) is a retrovirus with RNA as its genetic material. In RNA, adenine pairs with uracil. So, the number of adenine will not be equal to that of thymine.</span></p>",
      "correct_choice_id": 130796,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1970,
      "choices": [
        {
          "id": 7873,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Human cells can divide a finite number of times only</span></p>"
        },
        {
          "id": 7874,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Free radical oxidation level is unrestricted</span></p>"
        },
        {
          "id": 7875,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Telomerase activity is unrestricted</span></p>"
        },
        {
          "id": 7876,
          "text": "<p><span style=\"font-size:12.0pt;\">RNA polymerase can function for a finite number of times only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is true about the Hayflick limit? (</span>INICET May 2020)</p>",
      "unique_key": "Q6839239",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601282,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Human cells can divide a finite number of times only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Leonard Hayflick discovered that cultured normal human cells have limited capacity to divide, after which they become senescent — a phenomenon now known as the ‘Hayflick limit’</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Each time a cell undergoes mitosis, the telomeres on the ends of each chromosome shorten slightly. Cell division will cease once telomeres shorten to a critical length. Hayflick interpreted his discovery to be aging at the cellular level. The aging of cell populations appears to correlate with the overall physical aging of an organism. <strong>Normal human fetal cell population will divide between 40 and 60 times in cell culture before entering a senescence phase. However, this limit does not apply to stem cells.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Free radical oxidation level is unrestricted: </strong>Free radical oxidation is related to oxidative stress and damage but is not directly related to the Hayflick limit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Telomerase activity is unrestricted: </strong>In most somatic cells, telomerase activity is limited, leading to telomere shortening. However, certain cells like stem cells and cancer cells exhibit higher telomerase activity, allowing them to bypass the Hayflick limit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. RNA polymerase can function for a finite number of times only: </strong>RNA polymerase activity is not directly linked to the Hayflick limit and does not have a finite number of times it can function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hayflick limit describes the finite number of times that normal human cells can divide before they become senescent, primarily due to telomere shortening.</span></p>",
      "correct_choice_id": 7873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4578,
      "choices": [
        {
          "id": 18288,
          "text": "<p><span style=\"font-size:12.0pt;\">Albinism</span></p>"
        },
        {
          "id": 18289,
          "text": "<p><span style=\"font-size:12.0pt;\">G-6-PD deficiency</span></p>"
        },
        {
          "id": 18290,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan's syndrome</span></p>"
        },
        {
          "id": 18291,
          "text": "<p><span style=\"font-size:12.0pt;\">Lesch-Nyhan syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following diseases have autosomal recessive inheritance? (NEET PG 2019)</span></p>",
      "unique_key": "Q6563962",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Albinism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Albinism&nbsp;</strong>is typically inherited in an autosomal recessive manner. To have albinism, an individual must inherit two copies of the mutated gene for albinism, one from each parent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. G-6-PD deficiency:&nbsp;</strong>Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency is inherited in an X-linked recessive manner, not autosomal recessive. It affects males more often than females.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Marfan's syndrome:&nbsp;</strong>Marfan's syndrome is inherited in an autosomal dominant manner, not autosomal recessive. A single copy of the mutated gene from one parent is enough to cause the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lesch-Nyhan syndrome:&nbsp;</strong>Lesch-Nyhan syndrome is inherited in an X-linked recessive manner. It primarily affects males who inherit the mutated gene from their carrier mothers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/screenshot-2024-01-03-161554_K9X19gw.jpg\" alt=\"\" width=\"1000\" height=\"920\"></p>",
      "correct_choice_id": 18288,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2046,
      "choices": [
        {
          "id": 8177,
          "text": "<p><span style=\"font-size:12.0pt;\">Methionine</span></p>"
        },
        {
          "id": 8178,
          "text": "<p><span style=\"font-size:12.0pt;\">Valine</span></p>"
        },
        {
          "id": 8179,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucine</span></p>"
        },
        {
          "id": 8180,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoleucine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In MSUD (Maple Syrup Urine disorder) which of the following is not restricted:</span>(INICET MAY 2022)</p>",
      "unique_key": "Q2955778",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601284,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Methionine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Methionine is not restricted in MSUD. MSUD is characterized by the inability to break down three specific branched-chain amino acids: Leucine, Isoleucine, and Valine. Methionine is not one of the amino acids that are restricted in the diet of individuals with MSUD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Valine: </strong>Valine is one of the amino acids restricted in MSUD. People with MSUD need to limit their intake of Valine as their bodies cannot properly metabolize it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Leucine: </strong>Leucine is another amino acid that is restricted in MSUD. It is one of the three branched-chain amino acids that individuals with MSUD need to limit in their diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Isoleucine: </strong>Isoleucine is also restricted in MSUD. Like Valine and Leucine, Isoleucine is a branched-chain amino acid that individuals with MSUD need to restrict to manage the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Maple Syrup Urine Disease (MSUD) occurs due to the inherited deficiency of branched Chain Keto-acid Decarboxylase resulting in defect in oxidative decarboxylation and catabolism of branched chain amino acids Valine, Isoleucine and leucine. As a result, these amino acids accumulate and are excreted in urine. So, for the treatment, these BCAA should be restricted in diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methionine is a sulphur containing amino acid and do not require this enzyme for its metabolism. So, its restriction is not required in MSUD.&nbsp;&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Harper’s 31<sup>st</sup> ed/pg- 290</strong></span></p>",
      "correct_choice_id": 8177,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2444,
      "choices": [
        {
          "id": 9762,
          "text": "<p><span style=\"font-size:12.0pt;\">RT PCR</span></p>"
        },
        {
          "id": 9763,
          "text": "<p><span style=\"font-size:12.0pt;\">Sanger's technique</span></p>"
        },
        {
          "id": 9764,
          "text": "<p><span style=\"font-size:12.0pt;\">Next generation sequencing</span></p>"
        },
        {
          "id": 9765,
          "text": "<p><span style=\"font-size:12.0pt;\">Western blot</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following techniques is based on RNA? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q1104644",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601285,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) RT-PCR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>RT PCR is RNA-based technique</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is the method used to amplify, isolate or identify a known sequence from a cell or tissue RNA library. <strong>Essentially normal PCR is preceded by reverse transcription (to convert the RNA to cDNA).</strong> This is widely used in expression mapping, determining when and where certain genes are expressed<strong>. T<sup>th</sup> polymerase from Thermus thermophilus may be used</strong>. This enzyme <strong>has both DNA polymerase and reverse transcriptase activities at high temperature</strong>. This allows both cDNA synthesis from mRNA followed by PCR amplification.</span></p><p><span style=\"font-size:12.0pt;\">In ordinary PCR, DNA is detected; that DNA could be from a living or non-living organism. But in reverse PCR, mRNA is detected; that means, it is derived from a living organism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Sanger's technique</strong> - Sanger sequencing, also known as the <strong>“chain termination method”</strong>, is a method for determining the nucleotide sequence of DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Next-generation DNA sequencing&nbsp;</strong>technologies also called <strong>deep sequencing</strong>, is a technology that enables parallel multiplexed <strong>analysis of DNA sequences on a massive scale.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Western&nbsp;</strong>blot is used to detect <strong>specific protein.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">RT-PCR is an RNA-based technique that involves reverse transcription of RNA into cDNA followed by PCR amplification, widely used in gene expression analysis.</span></p>",
      "correct_choice_id": 9762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31892,
      "choices": [
        {
          "id": 127438,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver</span></p>"
        },
        {
          "id": 127439,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreas</span></p>"
        },
        {
          "id": 127440,
          "text": "<p><span style=\"color:#212529;font-size:12.0pt;\">Muscle and adipose tissues</span></p>"
        },
        {
          "id": 127441,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following tissues are dependent on insulin for glucose uptake?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q3150198",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601286,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Muscle and adipose tissues</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GLUT-4 glucose transporter is insulin dependent and is the only GLUT present in muscle and adipose tissues. So, muscles and adipose tissues are totally dependent on Insulin for glucose uptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Liver:</strong> The liver uses GLUT-2 transporters for glucose uptake, which are not insulin-dependent. GLUT-2 allows the liver to take up glucose and store it as glycogen or use it for energy production, independent of insulin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pancreas:</strong> The pancreas also uses GLUT-2 transporters for glucose uptake, which are not insulin-dependent. In the pancreas, GLUT-2 plays a role in sensing blood glucose levels and regulating insulin secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Placenta:</strong> The placenta uses GLUT-1 and GLUT-3 transporters for glucose uptake, which are not insulin-dependent. These transporters facilitate the basal uptake of glucose to support the energy needs of the placenta and fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115921.jpg\" alt=\"\" width=\"1000\" height=\"549\"></strong></span></p>",
      "correct_choice_id": 127440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57696,
      "choices": [
        {
          "id": 230153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">N-formylmethionine</span></span></span></p>"
        },
        {
          "id": 230154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Selenocysteine</span></span></span></p>"
        },
        {
          "id": 230155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">&gamma;-Carboxyglutamate</span></span></span></p>"
        },
        {
          "id": 230156,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphoserine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 30-year-old researcher is studying various amino acids and their incorporation into proteins during post-translational modifications. During a discussion on how certain amino acids are synthesized and integrated into proteins, he comes across an amino acid that is incorporated directly during translation rather than being formed through post-translational modification. Which of the following amino acids is not produced through post-translational modification?</span></span></span></p>",
      "unique_key": "Q1715636",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601287,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: B. Selenocysteine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Selenocysteine, often referred to as the 21st amino acid, is unique because it is directly incorporated into proteins during translation, rather than being formed through post-translational modification. It is encoded by the UGA codon, which usually signals a stop but is recoded to incorporate selenocysteine due to the presence of a specific secondary structure in the mRNA called the Selenocysteine Insertion Sequence (SECIS). The synthesis of selenocysteine involves replacing the oxygen of serine with selenium. It plays a crucial role in the active sites of several enzymes, such as thioredoxin reductase, glutathione peroxidase, and deiodinases, which are important for antioxidant defense and thyroid hormone metabolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. N-formylmethionine:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> N-formylmethionine is a modified form of methionine that serves as the initiator amino acid in bacterial protein synthesis. It is a result of a post-translational modification that adds a formyl group to methionine, unlike selenocysteine which is directly incorporated during translation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. &gamma;-Carboxyglutamate:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This modified form of glutamate is generated through post-translational carboxylation, which is essential in blood clotting factors to bind calcium ions, a key step in the coagulation cascade.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Phosphoserine:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Phosphoserine is formed by the phosphorylation of serine residues in proteins, a common post-translational modification that plays a significant role in regulating protein function, unlike selenocysteine which is directly integrated during protein synthesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Selenocysteine is distinct among amino acids as it is incorporated during translation rather than being modified post-translationally. This unique incorporation mechanism highlights its specialized role in the active sites of specific enzymes, emphasizing the critical nature of direct incorporation for its biological functions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-19-112713.jpg\" style=\"height:646px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 230154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4903,
      "choices": [
        {
          "id": 19587,
          "text": "<p><span style=\"font-size:12.0pt;\">Mismatch repair</span></p>"
        },
        {
          "id": 19588,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleotide excision repair</span></p>"
        },
        {
          "id": 19589,
          "text": "<p><span style=\"font-size:12.0pt;\">Base excision repair</span></p>"
        },
        {
          "id": 19590,
          "text": "<p><span style=\"font-size:12.0pt;\">Homologous recombinant repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient who is a diagnosed case of HNPCC, which of the following is the most common repair associated with it? (</span>NEET PG 2021)</p>",
      "unique_key": "Q4576543",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601308,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mismatch repair</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mismatch Repair (MMR) defect leads to Hereditary Non-Polyposis Colorectal Cancer (HNPCC). This mechanism corrects errors that typically occur during DNA replication. Mutations in MMR genes result in microsatellite instability and contribute to the development of various cancers at an early age. In contrast, Homologous Repair (HR) defects are associated with other genetic disorders and cancers, including Bloom syndrome, Werner syndrome, breast cancer, and Ataxia-Telangiectasia like disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nucleotide excision repair:&nbsp;</strong>Incorrect for this context as it deals with the repair of bulky helix-distorting lesions caused by UV radiation and chemicals, leading to diseases like Xeroderma pigmentosum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Base excision repair:&nbsp;</strong>Incorrect as it fixes small non-helix-distorting bases caused by spontaneous or induced changes, leading to conditions like MUTYH-associated polyposis when defective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Homologous recombinant repair:&nbsp;</strong>Incorrect for HNPCC. It repairs double-strand breaks or interstrand cross-links in DNA, not typically involved in the pathogenesis of HNPCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-175723.jpg\" alt=\"\" width=\"1000\" height=\"403\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>- Harper 31<sup>st</sup> e/pg. 370</strong></span></p>",
      "correct_choice_id": 19587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2023,
      "choices": [
        {
          "id": 8085,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        },
        {
          "id": 8086,
          "text": "<p><span style=\"font-size:12.0pt;\">Vit B<sub>12</sub></span></p>"
        },
        {
          "id": 8087,
          "text": "<p><span style=\"font-size:12.0pt;\">Vit B<sub>1</sub></span></p>"
        },
        {
          "id": 8088,
          "text": "<p><span style=\"font-size:12.0pt;\">Vit B<sub>6</sub></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Methyl tetrahydrofolate accumulation and functional deficiency of folate is seen in the deficiency of: (</span>INICET May 2021)</p>",
      "unique_key": "Q1815594",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601309,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Vit B<sub>12</sub></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin B12, also known as cobalamin, is essential for DNA synthesis and plays a role in the conversion of methyl tetrahydrofolate to its active form. Deficiency of vitamin B12 can lead to the functional deficiency of folate because it impairs the regeneration of tetrahydrofolate from methyl tetrahydrofolate, leading to the accumulation of the latter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Folic acid:</strong> Folic acid, also known as vitamin B9, is a crucial vitamin required for DNA synthesis, cell division, and various metabolic processes. In cases of folic acid deficiency, methyl tetrahydrofolate can accumulate, but there is no direct deficiency of vitamin B12. Folic acid deficiency primarily affects folate-dependent reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Vit B1:</strong> Vitamin B1, also known as thiamine, is not directly related to the metabolism of folate or methyl tetrahydrofolate. It primarily plays a role in carbohydrate metabolism as a cofactor for enzymes involved in the citric acid cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Vit B6:</strong> Vitamin B6, also known as pyridoxine, is involved in various enzymatic reactions, including those related to amino acid metabolism. It is not directly associated with the metabolism of folate or methyl tetrahydrofolate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To understand the metabolic consequences of vitamin deficiencies, medical students should recognize that the functional deficiency of folate, characterized by the accumulation of methyl tetrahydrofolate, is primarily seen in vitamin B12 deficiency, making it important to distinguish between the two deficiencies in clinical practice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Deficiency of Vitamin B12 leads to accumulation of methyl THF. Free THF becomes deficient (Folate Trap) and as THF is functional form of folate it is also known as functional deficiency of folate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/11.jpg\" alt=\"\" width=\"500\" height=\"354\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Ref - Harper 31<sup>st</sup> e/p 536</strong></i></span></p>",
      "correct_choice_id": 8086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1931,
      "choices": [
        {
          "id": 7717,
          "text": "<p><span style=\"font-size:12.0pt;\">Paternity test</span></p>"
        },
        {
          "id": 7718,
          "text": "<p><span style=\"font-size:12.0pt;\">Maternity test</span></p>"
        },
        {
          "id": 7719,
          "text": "<p><span style=\"font-size:12.0pt;\">Personal identification</span></p>"
        },
        {
          "id": 7720,
          "text": "<p><span style=\"font-size:12.0pt;\">Organ transplantation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Chimeric DNA is used for? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q8669133",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601310,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Organ transplantation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chimeric DNA (also known a recombinant DNA) is used in organ transplantation, especially in bone marrow transplant. </strong>It allows for the production of essential therapeutic proteins and other biological products.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Paternity test:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Uses genetic markers to determine biological parentage.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Typically uses DNA fingerprinting rather than chimeric DNA technology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Maternity test:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Similar to paternity testing, using genetic markers for parentage.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> Uses DNA fingerprinting, not chimeric DNA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Personal identification:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Uses DNA profiling for forensic and legal identification.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relevance:</strong> DNA fingerprinting and STR analysis are common methods, not chimeric DNA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Uses of Chimeric DNA are:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Recombinant human insulin</span></li><li><span style=\"font-size:12.0pt;\">Recombinant human growth hormone (HGH, somatotropin) and other human hormones (e.g. FSH)</span></li><li><span style=\"font-size:12.0pt;\">Recombinant blood clotting factor VIII and other clotting factors (Factor IX, tPA, hirudin)</span></li><li><span style=\"font-size:12.0pt;\">Recombinant hepatitis B vaccine, HPV vaccine, etc.</span></li><li><span style=\"font-size:12.0pt;\">Cytokines and growth factors (interferon, interleukins, etc.)</span></li><li><span style=\"font-size:12.0pt;\">Monoclonal antibodies and other related products (rituximab, trastuzumab, etc.)</span></li><li><span style=\"font-size:12.0pt;\">Recombinant enzymes (acid α glucosidase [myozyme], α L iduronidase [aldurazyme])</span></li><li><span style=\"font-size:12.0pt;\">Recombinant HIV protein for HIV ELISA testing</span></li><li><span style=\"font-size:12.0pt;\">Herbicide and insect resistant crops</span></li><li><span style=\"font-size:12.0pt;\">Other products: Bone morphogenic protein (BMP), albumin, fibinolytic and thrombolytic agents, etc.</span></li><li><span style=\"font-size:12.0pt;\">Gene mapping using techniques such as fluorescence in sit hybridization (FISH).</span></li><li><span style=\"font-size:12.0pt;\">Molecular analysis of disease, to detect gene variations and mutations.</span></li><li><span style=\"font-size:12.0pt;\">Restriction Fragment Length polymorphism (RFLP) and single nucleotide polymorphism (SN)</span></li><li><span style=\"font-size:12.0pt;\">Microsatellite DNA polymorphisms</span></li><li><span style=\"font-size:12.0pt;\">Gene therapy and bone marrow transplantation</span></li></ol>",
      "correct_choice_id": 7720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2830,
      "choices": [
        {
          "id": 11305,
          "text": "<p><span style=\"font-size:12.0pt;\">Triglycerides</span></p>"
        },
        {
          "id": 11306,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphoglycerol</span></p>"
        },
        {
          "id": 11307,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycolipids</span></p>"
        },
        {
          "id": 11308,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingolipids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an amphipathic Lipid? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q3781944",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601311,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Triglycerides</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Triglycerides are not amphipathic lipids. They consist of three fatty acid chains esterified to a glycerol molecule. These molecules are hydrophobic and do not have a polar or hydrophilic region. Triglycerides are the primary storage form of energy in the body and are commonly found in adipose tissue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Phosphoglycerol: </strong>Phosphoglycerol, also known as phosphoglyceride or glycerophospholipid, is an amphipathic lipid. It has a polar phosphate head group and two hydrophobic fatty acid tails. Phosphoglycerides are essential components of cell membranes, where they form the lipid bilayer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glycolipids: </strong>Glycolipids are amphipathic lipids. They have a hydrophilic carbohydrate (sugar) head group and hydrophobic lipid tails. Glycolipids are important in cell membranes, particularly in nerve cells and the myelin sheath. They play a role in cell signaling and recognition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sphingolipids: </strong>Sphingolipids are amphipathic lipids. They consist of a sphingosine backbone, a hydrophilic head group (usually containing a sugar), and one or two hydrophobic fatty acid tails. Sphingolipids are crucial components of cell membranes and are involved in various cellular processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Triglycerides are not amphipathic lipids, while phosphoglycerol, glycolipids, and sphingolipids are amphipathic and play important roles in cell membrane structure and function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are formed by esterification between three Fatty acids and one glycerol molecule. As Ester bond is non-polar so, molecule of TG is a non-polar. They are also called as neutral fats.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/5_RQ4Z1Io.jpg\" alt=\"\" width=\"300\" height=\"385\"></span></p>",
      "correct_choice_id": 11305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2531,
      "choices": [
        {
          "id": 10109,
          "text": "<p><span style=\"font-size:12.0pt;\">Collagen</span></p>"
        },
        {
          "id": 10110,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucin</span></p>"
        },
        {
          "id": 10111,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        },
        {
          "id": 10112,
          "text": "<p><span style=\"font-size:12.0pt;\">Immunoglobulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following has protective as well as lubricating property? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4059582",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601312,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mucin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mucins form a <strong>protective barrier on epithelial surfaces</strong>. They are also found in secretions of the gastrointestinal, respiratory and urogenital tract. They also have <strong>lubricating properties</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Functions of Mucin:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Membrane-bound mucins participate in various cell-cell interactions.</span></li><li><span style=\"font-size:12.0pt;\">Protective barrier on epithelial surfaces.</span></li><li><span style=\"font-size:12.0pt;\">Lubricating properties.</span></li><li><span style=\"font-size:12.0pt;\">\"Mask\" certain surface antigens.</span></li><li><span style=\"font-size:12.0pt;\">Mucins also carry cancer-specific peptide and carbohydrate epitopes.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Salient features of Mucin:</strong></span></p><ol style=\"list-style-type:upper-roman;\"><li><span style=\"font-size:12.0pt;\"><strong>Found in secretions</strong> of the gastrointestinal, respiratory, and reproductive tracts and also in membranes of various cells.</span></li><li><span style=\"font-size:12.0pt;\">Exhibit <strong>high content of O-glycan chains</strong>, usually containing NeuAc.</span></li><li><span style=\"font-size:12.0pt;\">Contain repeating amino acid sequences <strong>rich in serine, threonine, and proline</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Extended structure contributes to their <strong>high viscoelasticity</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Collagen:</strong> Collagen provides structural support and strength to tissues but does not have significant lubricating properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Albumin:</strong> Albumin is a major plasma protein involved in maintaining osmotic pressure and transporting various substances but does not have lubricating properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Immunoglobulin:</strong> Immunoglobulins are antibodies that play a crucial role in immune response but do not provide lubrication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">Mucins have both protective and lubricating properties, forming a barrier on epithelial surfaces and reducing friction in various body tracts. They are essential for maintaining the integrity and function of mucosal surfaces.</span></p>",
      "correct_choice_id": 10110,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2547,
      "choices": [
        {
          "id": 10173,
          "text": "<p><span style=\"font-size:12.0pt;\">W, X, Y</span></p>"
        },
        {
          "id": 10174,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿W, Z</span></p>"
        },
        {
          "id": 10175,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿WX</span></p>"
        },
        {
          "id": 10176,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿W Y</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The illustration below shows alternative splicing of a gene which has intron segments 1, 2, 3, 4, and 5. It yields two products A and B, by the action of different promoters. You are provided with the promoters W, X, Y, and Z, each of which binds to a different segment as shown below and acts in the marked direction. Which of the following promoters will you use to get product A? (INICET Nov 2020)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><img class=\"image_resized\" style=\"aspect-ratio:400/235;width:90.94%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/06/whatsapp-image-2023-06-12-at-190121011090.jpg\" alt=\"\" width=\"400\" height=\"235\"></p>",
      "unique_key": "Q7280025",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601313,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. W Y</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A promoter is a region of DNA upstream of a gene where relevant proteins bind to initiate</span></p><p><span style=\"font-size:12.0pt;\">transcription of that gene. In the case of this question, product A is formed by including specific</span></p><p><span style=\"font-size:12.0pt;\">segments and excluding others through the process of alternative splicing.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Sequence A consists of segments 1, 3, 4, and 5.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Promoter W Required for segment 1.</span></li><li><span style=\"font-size:12.0pt;\">Promoter Y Required for segments 3, 4, and 5.</span></li><li><span style=\"font-size:12.0pt;\">Segment 2 is excluded during alternative splicing.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, the combination of Promoters W and Y will result in the production of sequence A by including</span></p><p><span style=\"font-size:12.0pt;\">the correct segments and excluding segment 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p><span style=\"font-size:12.0pt;\"><strong>Option a (W, X, Y)</strong>: This combination Required Promoter X, for segment 2, but it</span></p><p><span style=\"font-size:12.0pt;\">is unnecessary since W and Y alone are sufficient to yield product A.</span></p></li><li><span style=\"font-size:12.0pt;\"><strong>Option b (W, Z)</strong>: Promoter Z does not include segments 3, making this option incorrect for generating product A.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option c (WX)</strong>: Promoters W and X are insufficient because they do not include segments 3, 4, and 5, which are essential for product A.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A promoter is a region of DNA upstream of a gene where relevant proteins bind to initiate</span></p><p><span style=\"font-size:12.0pt;\">transcription of that gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Using promoters W, Y will yield product A by including segments 1, 3, 4, and 5 and removing segment 2 through alternative splicing.</span></p>",
      "correct_choice_id": 10176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57697,
      "choices": [
        {
          "id": 230157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Methylation</span></span></span></p>"
        },
        {
          "id": 230158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Acetylation</span></span></span></p>"
        },
        {
          "id": 230159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">t-RNA synthesis</span></span></span></p>"
        },
        {
          "id": 230160,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA replication</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">What is the primary role of CG islands in our DNA? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q8048763",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601314,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A. Methylation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">CG islands, also known as CpG islands, are regions rich in cytosine and guanine dinucleotides in which the cytosine residues can be methylated. This methylation process plays a crucial role in regulating gene expression by affecting the accessibility of DNA to transcription machinery, thereby influencing whether genes are active or silenced.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">b. Acetylation</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Incorrect because acetylation typically involves histones, not directly the DNA or specific DNA regions like CG islands.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">c. t-RNA synthesis</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Incorrect as t-RNA synthesis is not directly related to CG islands; it generally occurs in the nucleolus and involves RNA polymerase III.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">d. DNA replication</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Incorrect because, while CG islands may influence the overall structure and replication timing of the genome, they are not directly involved in the replication process itself.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">CG islands are crucial for the methylation of DNA, a key epigenetic mechanism that regulates gene expression without altering the DNA sequence itself.</span></span></span></p>",
      "correct_choice_id": 230157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4748,
      "choices": [
        {
          "id": 18967,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein folding</span></p>"
        },
        {
          "id": 18968,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-translational modification</span></p>"
        },
        {
          "id": 18969,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein degradation</span></p>"
        },
        {
          "id": 18970,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein sorting</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the function of the proteasome? (</span>NEET PG 2020)</p>",
      "unique_key": "Q1969215",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601315,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Protein degradation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary function of the proteasome is to degrade intracellular proteins. It plays a crucial role in maintaining cellular homeostasis by breaking down unneeded or damaged proteins. Proteins are targeted for degradation by being tagged with a small protein called ubiquitin, and the proteasome then recognizes and degrades these ubiquitinated proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Protein folding</strong>: The proteasome is not involved in protein folding. Protein folding is a process where newly synthesized proteins attain their three-dimensional, functional structures. It typically occurs in the endoplasmic reticulum (ER) and is assisted by chaperone proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Post-translational modification</strong>: While some post-translational modifications of proteins can occur in the proteasome, its primary function is not post-translational modification. Post-translational modifications include processes like phosphorylation, glycosylation, and ubiquitination, which may occur on proteins both before and after they enter the proteasome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Protein sorting</strong>: Protein sorting involves directing proteins to their correct cellular locations, such as organelles like the mitochondria or lysosomes. The proteasome's main function is not related to protein sorting but rather protein degradation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ubiquitin tagged proteins are immediately broken down inside the proteasomes of the cells</strong>. The proteasome assembly has a central cylindrical hollow core. <strong>Ubiquitin-tagged proteins are taken into this barrel, and surrounding proteolytic enzymes digest the protein</strong> into small oligopeptides of 5-6 amino acids length</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>proteasome is a cylindrical structure</strong> in the cytosol that <strong>degrades polyubiquitinated proteins</strong>. It has a central core with proteolytic enzymes. Proteins that are tagged by ubiquitin to be degraded enter the core through regulatory rings on either side of the cylinder.&nbsp;&nbsp;&nbsp;&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It plays the major role in the degradation of proteins, and is particularly associated with disposal of misfolded proteins and regulatory enzymes that have short half-lives.&nbsp;</span></p>",
      "correct_choice_id": 18969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32742,
      "choices": [
        {
          "id": 130818,
          "text": "<p><span style=\"font-size:12pt;\">Haem part of Hb</span></p>"
        },
        {
          "id": 130819,
          "text": "<p><span style=\"font-size:12pt;\">Globin part of Hb</span></p>"
        },
        {
          "id": 130820,
          "text": "<p><span style=\"font-size:12pt;\">Haem part of Myoglobin</span></p>"
        },
        {
          "id": 130821,
          "text": "<p><span style=\"font-size:12pt;\">Globin part of Myoglobin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">2,3 BPG binds to: (</span>INICET Nov 2023)</p>",
      "unique_key": "Q8923263",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601316,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Globin part of Hb</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2,3-BPG binds to the globin part of hemoglobin. The binding of 2,3-BPG reduces the oxygen affinity of hemoglobin, promoting the release of oxygen in tissues where it is needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> This option is not accurate. 2,3-BPG does not directly bind to the heme group of hemoglobin. Instead, it interacts with the globin chains of hemoglobin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Haem part of Myoglobin:</strong></span></p><ul><li><span style=\"font-size:12pt;\">This option is not accurate. Myoglobin is a single-chain protein, and it does not contain heme groups like hemoglobin. Myoglobin directly binds oxygen to store it in muscle tissues, but it does not interact with 2,3-BPG.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Globin part of Myoglobin:</strong></span></p><ul><li><span style=\"font-size:12pt;\">This option is not accurate. Myoglobin is a single-chain protein, and it does not contain globin chains like hemoglobin. Myoglobin directly binds oxygen in muscle tissues but does not interact with 2,3-BPG.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2,3 BPG has negative charge whereas beta chain of hemoglobin has large positive charges due to amino acids His and Lys. Together they form the salt bridges (see fig) which promote formation of taut conformation and helps in deoxygenation.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/10/21.jpg\" alt=\"\" width=\"500\" height=\"500\"></p>",
      "correct_choice_id": 130819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3005,
      "choices": [
        {
          "id": 12005,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium</span></p>"
        },
        {
          "id": 12006,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 Phosphate</span></p>"
        },
        {
          "id": 12007,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 12008,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Glycogen phosphorylase is activated by? (INICET Nov 2022)</span></p>",
      "unique_key": "Q8872417",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601317,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Calcium</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Glycogen phosphorylase is primarily activated indirectly by calcium ions. An increase in intracellular calcium levels triggers the activation of phosphorylase kinase, which, in turn, activates glycogen phosphorylase. Calcium acts as a secondary messenger to stimulate this cascade of enzymatic reactions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.</strong>&nbsp;<strong>Glucose 6 Phosphate</strong>: Glucose 6-phosphate, a product of glycogenolysis (glycogen breakdown), actually inhibits glycogen phosphorylase. It is part of a negative feedback mechanism to prevent excessive glycogen breakdown when glucose levels are sufficient.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C.</strong>&nbsp;<strong>Insulin</strong>: Insulin does not directly activate glycogen phosphorylase. Instead, insulin plays a role in promoting glycogen synthesis by activating glycogen synthase and inhibiting glycogen phosphorylase.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.</strong>&nbsp;<strong>Glucose</strong>: Glucose itself does not directly activate glycogen phosphorylase. In fact, high levels of glucose signal that glucose is available for energy production, leading to the inhibition of glycogenolysis and glycogen phosphorylase.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Glycogen phosphorylase is activated indirectly through the calcium signaling pathway, which initiates a series of enzymatic reactions ultimately leading to the activation of glycogen phosphorylase. This mechanism allows the regulation of glycogen breakdown in response to cellular energy needs.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/01.jpg\" alt=\"\" width=\"700\" height=\"439\"></span></p>",
      "correct_choice_id": 12005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11129,
      "choices": [
        {
          "id": 44482,
          "text": "<p><span style=\"font-size:18px;\">Point A</span></p>"
        },
        {
          "id": 44483,
          "text": "<p><span style=\"font-size:18px;\">Point B</span></p>"
        },
        {
          "id": 44484,
          "text": "<p><span style=\"font-size:18px;\">Point C</span></p>"
        },
        {
          "id": 44485,
          "text": "<p><span style=\"font-size:18px;\">Point D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A diagram illustrating the natural history of a disease has points marked A, B, C, and D. Which point indicates the onset of symptoms in the disease's natural history? </strong><i><strong>[AIIMS NOV 2017]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip33.jpg\" alt=\"\" width=\"668\" height=\"261\"></strong></span></p>",
      "unique_key": "Q2907843",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601318,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Point C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Point C:</strong> Marks onset of clinical signs and symptoms</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Point A:&nbsp;</strong>Entry of infectious agent into the host.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Point B:&nbsp;</strong>Pathological and physiological changes occur in the stage of the subclinical phase. These changes are induced by the causative agent but are not sufficient enough to cause clinical signs and symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Point D:&nbsp;</strong>Usual time of diagnosis at which clinical signs and symptoms are well evident.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip34.jpg\" alt=\"\" width=\"700\" height=\"311\"></span></p>",
      "correct_choice_id": 44484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20871,
      "choices": [
        {
          "id": 83448,
          "text": "<p><span style=\"font-size:12pt;\">Mallory-Weiss tear</span></p>"
        },
        {
          "id": 83449,
          "text": "<p><span style=\"font-size:12pt;\">Esophagitis</span></p>"
        },
        {
          "id": 83450,
          "text": "<p><span style=\"font-size:12pt;\">Peptic ulcer</span></p>"
        },
        {
          "id": 83451,
          "text": "<p><span style=\"font-size:12pt;\">Esophageal varices</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents in emergency department with sudden hematemesis. He has been taking aspirin for his arthritis and drinks alcohol occasionally. He gives a history of occasional abdominal pain. On examination, there is no abdominal mass or tenderness. What is the likely diagnosis?(NEET PG 2023)</span></p>",
      "unique_key": "Q5983305",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601319,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Peptic ulcer</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This patient most likely has a bleeding peptic ulcer.</span></li><li><span style=\"font-size:12pt;\">&nbsp;Peptic ulcer disease (PUD) includes both gastric and duodenal ulcers.</span></li><li><span style=\"font-size:12pt;\">&nbsp;Aspirin, an NSAID, interferes with the protective role of prostaglandins on the gastric and duodenal mucosa, increasing the risk of peptic ulcer formation in the stomach and the duodenum.</span></li><li><span style=\"font-size:12pt;\">&nbsp;Common presentations of peptic ulcers include pain in the epigastrium, bleeding, and vomiting.</span></li><li><span style=\"font-size:12pt;\">The history of aspirin use and alcohol consumption further supports the diagnosis of a peptic ulcer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Peptic Ulcer Disease (PUD)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Etiology:</strong> Helicobacter pylori infection and NSAID use.</span></li><li><span style=\"font-size:12pt;\"><strong>Mechanism:</strong> NSAIDs like aspirin disrupt the protective mucosal layer, leading to ulcer formation.</span></li><li><span style=\"font-size:12pt;\"><strong>Symptoms:</strong> Epigastric pain, hematemesis, melena.</span></li><li><span style=\"font-size:12pt;\"><strong>Sequelae:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Bleeding (more common in duodenal ulcers)</span></li><li><span style=\"font-size:12pt;\">Perforation leading to peritonitis</span></li><li><span style=\"font-size:12pt;\">Stricture causing gastric outlet obstruction</span></li><li><span style=\"font-size:12pt;\">Malignancy risk (only in gastric ulcers)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mallory-Weiss:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Occurs following repeated vomiting or retching, often associated with an alcoholic binge.</span></li><li><span style=\"font-size:12pt;\">Characterized by mucosal lacerations at the gastroesophageal junction.</span></li><li><span style=\"font-size:12pt;\">Presents with self-limiting hematemesis, not usually profuse.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Esophagitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Inflammation of the esophagus, often due to gastroesophageal reflux disease (GERD).</span></li><li><span style=\"font-size:12pt;\">Results in chronic blood loss and commonly presents as anemia rather than sudden hematemesis.</span></li><li><span style=\"font-size:12pt;\">Symptoms include heartburn, regurgitation, and dysphagia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Esophageal varices:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Dilated submucosal veins in the lower esophagus, often due to portal hypertension.</span></li><li><span style=\"font-size:12pt;\">Common in patients with liver cirrhosis.</span></li><li><span style=\"font-size:12pt;\">Presents with massive hematemesis, splenomegaly, and ascites, none of which are described in this patient.</span></li></ul><h3>&nbsp;</h3><h3><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Peptic ulcer disease (PUD) is a common cause of sudden hematemesis, especially in patients with risk factors such as NSAID use (e.g., aspirin) and occasional alcohol consumption.</span></li><li><span style=\"font-size:12pt;\">Recognition of these risk factors is crucial in diagnosing and managing PUD effectively.</span></li></ul>",
      "correct_choice_id": 83450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44836,
      "choices": [
        {
          "id": 178991,
          "text": "<p><span style=\"font-size:12pt;\">Cetuximab</span></p>"
        },
        {
          "id": 178992,
          "text": "<p><span style=\"font-size:12pt;\">Necitumumab</span></p>"
        },
        {
          "id": 178993,
          "text": "<p><span style=\"font-size:12pt;\">Pertuzumab</span></p>"
        },
        {
          "id": 178994,
          "text": "<p><span style=\"font-size:12pt;\">Panitumumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following drugs act as HER-1 inhibitors except (</span>INICET May 2024)</p>",
      "unique_key": "Q8535318",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Pertuzumab</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pertuzumab is a monoclonal antibody that targets HER-2 (Human Epidermal Growth Factor Receptor 2), not HER-1.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is used primarily in the treatment of HER-2 positive breast cancer.</span></li><li><span style=\"font-size:12pt;\">HER-1 (Human Epidermal Growth Factor Receptor 1) is also known as EGFR (Epidermal Growth Factor Receptor).&nbsp;</span></li><li><span style=\"font-size:12pt;\">Several monoclonal antibodies target EGFR, while others target different members of the HER family, such as HER-2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Cetuximab</strong>: Cetuximab is an EGFR (HER-1) inhibitor used primarily in the treatment of certain types of colorectal cancer and head and neck cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Necitumumab</strong>: Necitumumab is also an EGFR (HER-1) inhibitor, used in the treatment of metastatic squamous non-small cell lung cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Panitumumab</strong>: Panitumumab is an EGFR (HER-1) inhibitor, used in the treatment of metastatic colorectal cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given this information, the drug that does not act as a HER-1 inhibitor is:&nbsp;</span><br><span style=\"font-size:12pt;\"><strong>c. Pertuzumab</strong></span></p>",
      "correct_choice_id": 178993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9690,
      "choices": [
        {
          "id": 38727,
          "text": "<p><span style=\"font-size:12pt;\">Epidermal verrucous nevus</span></p>"
        },
        {
          "id": 38728,
          "text": "<p><span style=\"font-size:12pt;\">Congenital melanocytic nevus</span></p>"
        },
        {
          "id": 38729,
          "text": "<p><span style=\"font-size:12pt;\">Melanoacanthoma</span></p>"
        },
        {
          "id": 38730,
          "text": "<p><span style=\"font-size:12pt;\">Malignant melanoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition shown in image below? (</span>AIIMS May 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture3.jpg\" alt=\"\" width=\"298\" height=\"397\"></span></p>",
      "unique_key": "Q5241946",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601321,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Congenital melanocytic nevus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Picture shown above depicts a child with a <strong>well circumscribed, black, heterogenous lesion covered with hair</strong>. This is a characteristic lesion of congenital melanocytic nevus (CMN).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">CMNs are benign proliferations of nevus cells that are present at birth or develop shortly after. They are known for their variable pigmentation and the presence of terminal hair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Epidermal verrucous nevus:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Description: A type of <strong>epidermal nevus </strong>(skin lesion) that is characterized by a <strong>warty or rough </strong>appearance as seen in the below image.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture333335.jpg\" alt=\"\" width=\"300\" height=\"164\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: While these can be present at birth or appear later in life, they don't typically present as deeply pigmented lesions with dense hair.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Melanoacanthoma:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Description: A rare, <strong>benign</strong> skin lesion that typically presents as a <strong>rapidly growing, hyperpigmented patch or plaque as shown in the image below</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture422.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It has a combination of <strong>melanocytes and keratinocytes.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: Although melanoacanthomas are pigmented lesions, they <strong>don't</strong> typically have <strong>dense hair</strong> growth, making it less consistent with the provided description.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Malignant melanoma:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Description: A type of skin <strong>cancer</strong> that arises from <strong>melanocytes</strong>. It can appear as a new, <strong>irregularly-shaped mole </strong>with <strong>uneven color </strong>or a mole that changes in size, shape, or color.</span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: While malignant melanoma is a pigmented lesion, the hallmark features include <strong>asymmetry, border irregularity, color variation, and diameter enlargement</strong> (often referred to by the mnemonic ABCD) as seen in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture5666.jpg\" alt=\"\" width=\"300\" height=\"209\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The presence of dense hair is not a characteristic feature of <strong>melanoma.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Congenital Melanocytic Nevus (CMN):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Presentation:</strong> These nevi are typically pigmented and hairy and may vary in size. The presence of hair is a distinguishing feature that often helps differentiate them from other pigmented lesions.</span></li><li><span style=\"font-size:12pt;\"><strong>Risk Factors:</strong> Larger nevi have a higher risk of developing malignant melanoma later in life, but this is rare with smaller nevi.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong> Monitoring is essential, and in some cases, surgical removal may be considered for aesthetic reasons or to reduce melanoma risk, particularly in larger lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Rook's Textbook of Dermatology - 9th Edition Chapter 75 Page no 75.14</strong></span></p>",
      "correct_choice_id": 38728,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23203,
      "choices": [
        {
          "id": 92776,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-c, 4-a</span></p>"
        },
        {
          "id": 92777,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-d, 3-b, 4-a</span></p>"
        },
        {
          "id": 92778,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-d, 3-a, 4-b</span></p>"
        },
        {
          "id": 92779,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-d, 4-c</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Match the characteristics resulting from the compression of the listed structures in the event of thyroid enlargement.&nbsp;</span>(INICET MAY 2023)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/04/screenshot-2023-11-04-192025.png\" alt=\"\" width=\"700\" height=\"189\"></span></p>",
      "unique_key": "Q4081886",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601323,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 1-c, 2-d, 3-b, 4-a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Trachea - c. Dyspnea (Difficulty Breathing): </strong>Thyroid enlargement can lead to the compression of the trachea (windpipe), causing narrowing of the airway. This compression can result in difficulty breathing, also known as dyspnea.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Esophagus - d. Dysphagia (Difficulty Swallowing):</strong> When the thyroid gland enlarges and presses against the esophagus (the tube that carries food from the mouth to the stomach), it can interfere with the normal swallowing process, leading to dysphagia or difficulty swallowing.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sympathetic Chain - b. Horner's Syndrome</strong>: Compression of the sympathetic chain, which runs along the sides of the neck, can result in Horner's syndrome. Horner's syndrome includes signs such as ptosis (drooping of the upper eyelid), miosis (constricted pupil), and anhidrosis (lack of sweating) on one side of the face. Thyroid enlargement can affect sympathetic nerve fibers and lead to these symptoms.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent Laryngeal Nerve - a. Hoarseness:</strong> The recurrent laryngeal nerve innervates the muscles responsible for vocal cord movement. Compression or damage to this nerve due to thyroid enlargement can result in hoarseness of voice and voice changes.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-125556.JPG\" alt=\"\" width=\"700\" height=\"235\"></strong></span></p>",
      "correct_choice_id": 92777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1926,
      "choices": [
        {
          "id": 7697,
          "text": "<p><span style=\"font-size:12.0pt;\">TCA cycle</span></p>"
        },
        {
          "id": 7698,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycolytic pathway</span></p>"
        },
        {
          "id": 7699,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxidative phosphorylation</span></p>"
        },
        {
          "id": 7700,
          "text": "<p><span style=\"font-size:12.0pt;\">ETC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fluoroacetate is a component of pesticides. Which of the following metabolic pathways is inhibited by this compound? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4040333",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) TCA cycle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium fluoroacetate, is usually<strong> used as a rodenticide</strong>. It is highly toxic towards humans and other mammals through <strong>inhibition of the enzyme aconitase in the tricarboxylic acid cycle (metabolic uncoupler)</strong>, caused by 'lethal synthesis' of an isomer of <strong>fluorocitrate</strong> (FC). FA is found in a range of plant species and their ingestion can cause the death of ruminant animals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inhibition of the TCA Cycle by Fluoroacetate:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Aconitase:</strong> Converts citrate to aconitate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate is metabolized to fluorocitrate, which inhibits aconitase, leading to the accumulation of citrate and disruption of the TCA cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glycolytic pathway:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Converts glucose to pyruvate, generating ATP.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate does not affect glycolysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oxidative phosphorylation:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Produces ATP through the electron transport chain and ATP synthase.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate does not directly inhibit oxidative phosphorylation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. ETC (Electron Transport Chain):</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Transfers electrons from NADH and FADH2 to oxygen, generating ATP.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inhibition:</strong> Fluoroacetate does not directly inhibit the electron transport chain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inhibitors of TCA Cycle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-122100.jpg\" alt=\"\" width=\"1000\" height=\"219\"></strong></span></p>",
      "correct_choice_id": 7697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5758,
      "choices": [
        {
          "id": 23003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysgerminoma</span></span></span></p>"
        },
        {
          "id": 23004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endodermal sinus tumor</span></span></span></p>"
        },
        {
          "id": 23005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignant teratoma</span></span></span></p>"
        },
        {
          "id": 23006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucinous cystadenocarcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old female patient presents with an ovarian mass. On further evaluation, her serum biomarkers are found to be normal except for LDH, which is found to be elevated. The most likely diagnosis is:&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q3613268",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601325,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dysgerminoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical history of a 16-year-old female presenting with an ovarian mass with raised LDH points towards the diagnosis of dysgerminoma. Dysgerminomas usually arise in young women or in children, with an average incidence at the age of 20. They currently account for approximately one-third of all malignant ovarian germ cell tumors and are the most common malignant ovarian tumors found in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Endodermal sinus tumor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is typically associated with elevated alpha-fetoprotein (AFP), not LDH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Malignant teratoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This type of tumor does not typically present with elevated LDH as the sole abnormal marker.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mucinous cystadenocarcinoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This epithelial ovarian tumor is usually associated with elevated CA-125, not LDH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysgerminoma is the most likely diagnosis in a young female with an ovarian mass and elevated LDH levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 381, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57698,
      "choices": [
        {
          "id": 230161,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Urea</span></span></span></p>"
        },
        {
          "id": 230162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Alanine</span></span></span></p>"
        },
        {
          "id": 230163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Glutamate</span></span></span></p>"
        },
        {
          "id": 230164,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutamine</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">How is ammonia removed from the brain? (AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q1361171",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601327,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Answer: D. Glutamine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">In the brain, ammonia is detoxified by being converted into glutamine through the enzyme glutamine synthetase. This process combines glutamate with ammonia, safely encapsulating the ammonia for transport to the liver, where it can be further processed.<strong>&nbsp;&nbsp;</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Urea</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Ammonia is not directly converted into urea in the brain; rather, it is converted into glutamine, which is transported to the liver where urea synthesis occurs.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Alanine</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: While alanine does act as a carrier of ammonia in muscles by transamination reactions, it is not a primary pathway for ammonia removal in the brain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Glutamate</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Although glutamate is involved in the initial steps, it is the substrate that accepts ammonia to form glutamine, not the final carrier of ammonia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Glutamine acts as a non-toxic carrier of ammonia from the brain to the liver, where ammonia is further processed into urea, showcasing the brain&#39;s indirect participation in the urea cycle.</span></span></span></p>",
      "correct_choice_id": 230164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43269,
      "choices": [
        {
          "id": 172743,
          "text": "<p><span style=\"font-size:12pt;\">Permanent privation of hearing</span></p>"
        },
        {
          "id": 172744,
          "text": "<p><span style=\"font-size:12pt;\">Fracture femur</span></p>"
        },
        {
          "id": 172745,
          "text": "<p><span style=\"font-size:12pt;\">7 days admission in hospital</span></p>"
        },
        {
          "id": 172746,
          "text": "<p><span style=\"font-size:12.0pt;\">Emasculation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Grievous hurt under Section 320 IPC include all except: (INICET Nov 2023)</span></p>",
      "unique_key": "Q3363601",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601328,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. 7 days admission in hospital</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The duration of hospital stay alone does not define grievous hurt under IPC 320. The nature and severity of the injury are the determining factors, not the length of hospitalization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Grievous hurt under Section 320 IPC:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Permanent privation of hearing:</strong> This is considered grievous hurt as it results in the permanent loss of a sense, causing significant and lasting disability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Fracture femur:</strong> Fracture of the femur is explicitly mentioned under IPC 320 as grievous hurt due to the severity and potential long-term consequences of the injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Emasculation:</strong> This involves depriving a man of his masculine vigour and is considered grievous hurt due to the significant physical and psychological impact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Grievous hurt under IPC 320 involves injuries that cause permanent disability, severe bodily pain, or life-altering effects. Hospital stay duration alone does not qualify an injury as grievous hurt unless accompanied by a severe or specified injury under the law.</span></p>",
      "correct_choice_id": 172745,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11519,
      "choices": [
        {
          "id": 46042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 160/90 mmHg with one anti-hypertensive</span></span></span></span></p>"
        },
        {
          "id": 46043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with one anti-hypertensive</span></span></span></span></p>"
        },
        {
          "id": 46044,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with three or more anti hypertensives</span></span></span></span></p>"
        },
        {
          "id": 46045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 160/90 mmHg with three or more anti hypertensives</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension is defined as? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q5665159",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601329,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BP &gt; 140/90 mmHg with three or more anti hypertensives.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension is defined as blood pressure that remains above goal despite the concurrent use of three anti-hypertensive agents of different classes. Typically, one of the three medications should be a diuretic, and all agents should be prescribed at optimal dose amounts. The threshold set for defining resistant hypertension is blood pressure greater than 140/90 mmHg.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant hypertension indicates a situation where blood pressure control is inadequate despite the use of multiple medications, which can pose significant risks for cardiovascular complications and requires careful evaluation for secondary causes. This includes assessing for white-coat HTN/Pseudo HTN, medication adherence, lifestyle factors, and secondary causes of hypertension like renal artery stenosis, endocrine disorders, or medication-induced hypertension.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Home BP monitoring, ABPM (Ambulatory BP monitoring) can help in optimization of drugs.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistant HTN refers to BP &gt; 140/90 mmHg despite three anti-HTN, <em>one being a diuretic.</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21E/Cardiology/Hypertensive Disease/ chap 277&nbsp;&nbsp;&nbsp; </span></span></strong></span></span></p>",
      "correct_choice_id": 46044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11261,
      "choices": [
        {
          "id": 45010,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MR</span></span></span></span></p>"
        },
        {
          "id": 45011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOCM</span></span></span></span></p>"
        },
        {
          "id": 45012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VSD</span></span></span></span></p>"
        },
        {
          "id": 45013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MS</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following murmur increases on standing? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q9140682",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601330,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. HOCM</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur of Hypertrophic Obstructive Cardiomyopathy (HOCM) typically increases on standing. This is due to the decreased venous return and preload that occur with standing, which result in a reduction in the size of the left ventricular cavity. The smaller cavity size exacerbates the outflow obstruction under the aortic valve, thereby intensifying the murmur.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mitral Regurgitation (MR):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur associated with MR typically decreases when standing due to the decreased venous return and reduced volume load on the left ventricle, which lessens the regurgitant flow across the mitral valve.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ventricular Septal Defect (VSD):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur of a VSD generally decreases on standing due to reduced left to right shunting caused by decreased venous return.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mitral Stenosis (MS):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The murmur of mitral stenosis also decreases on standing. The reduction in preload lessens the flow through the narrowed mitral valve, subsequently reducing the intensity of the murmur.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the options listed, the murmur of Hypertrophic Obstructive Cardiomyopathy is unique in that it increases on standing, due to the specific hemodynamic changes that accentuate the outflow obstruction. This characteristic can be a crucial diagnostic clue in the clinical assessment of murmurs.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Physical examination of CVS/Chap 239</span></span></strong></p>",
      "correct_choice_id": 45011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3680,
      "choices": [
        {
          "id": 14699,
          "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 14700,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
        },
        {
          "id": 14701,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 14702,
          "text": "<p><span style=\"font-size:12.0pt;\">Amikacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is not used for typhoid fever in adults?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">NOV 2018)</span></p>",
      "unique_key": "Q5963322",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601332,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Amikacin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amikacin is not used in the treatment of typhoid fever as it is ineffective in clinical infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amikacin is an aminoglycoside. Despite showing efficient in vitro killing of Salmonella, first- and second-generation cephalosporins, and aminoglycosides have proven to be ineffective in actual clinical cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Azithromycin:</strong> This macrolide antibiotic is commonly used for treating typhoid fever, especially in cases where fluoroquinolone resistance is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ciprofloxacin:</strong> A fluoroquinolone antibiotic, it has been a standard treatment for typhoid fever, though resistance to this class is increasing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ceftriaxone:</strong> This third-generation cephalosporin is used to treat typhoid fever, particularly in cases of multidrug-resistant Salmonella typhi.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Amikacin is not effective in the treatment of typhoid fever, despite its efficacy in vitro against Salmonella.</span></p>",
      "correct_choice_id": 14702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6770,
      "choices": [
        {
          "id": 27049,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
        },
        {
          "id": 27050,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature</span></p>"
        },
        {
          "id": 27051,
          "text": "<p><span style=\"font-size:12.0pt;\">Touch</span></p>"
        },
        {
          "id": 27052,
          "text": "<p><span style=\"font-size:12.0pt;\">Pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pacinian corpuscle is stimulated by which of the following? (</span>INICET May 2021)</p>",
      "unique_key": "Q7584590",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601334,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pressure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pacinian corpuscle is stimulated by pressure.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pacinian corpuscles<strong> (Vater-Pacini or lamellar corpuscles)</strong> are the largest cutaneous mechanoreceptors for vibration and deep pressure and are essential for proprioception.</span></li><li><span style=\"font-size:12.0pt;\">They can be found throughout the whole body; however, it is the hands and feet where they occur most numerously and tightly grouped.</span></li><li><span style=\"font-size:12.0pt;\">They are composed of a nerve ending which is encapsulated by concentric layers of connective tissue that give it <strong>an onion-like appearance</strong> and are present in the dermis. The sensory nerves from cutaneous mechanoreceptors are myelinated Aα and Aβ fibers.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pain:&nbsp;</strong>Incorrect. Pain is detected by nociceptors, not Pacinian corpuscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Temperature:&nbsp;</strong>Incorrect. Temperature is detected by thermoreceptors, not Pacinian corpuscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Touch:&nbsp;</strong>Incorrect. Touch is detected by various mechanoreceptors, including Meissner's corpuscles and Merkel discs, but Pacinian corpuscles specifically detect deep pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pacinian corpuscles are specialized mechanoreceptors that detect deep pressure and vibration, playing a crucial role in proprioception and providing sensory feedback about the physical environment.</span></p>",
      "correct_choice_id": 27052,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13056,
      "choices": [
        {
          "id": 52186,
          "text": "<p><span style=\"font-size:12.0pt;\">It is called Argyl Robertson pupil.</span></p>"
        },
        {
          "id": 52187,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Both eyes are abnormal.</span></p>"
        },
        {
          "id": 52188,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿The vision is normal in right eye.</span></p>"
        },
        {
          "id": 52189,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Seen in optic neuritis, the pupil can paradoxically dilate in the both eyes.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is correct regarding the image given below: (</span>AIIMS May 2019)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-316.jpg\" alt=\"\" width=\"200\" height=\"324\"></p><p style=\"text-align:justify;\">&nbsp;</p>",
      "unique_key": "Q6966146",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Seen in optic neuritis, the pupil can paradoxically dilate in the both eyes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image suggests Marcus Gunn pupil, which is seen in optic neuritis. The right eye is affected, while the left eye is normal.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">﻿﻿The condition is named after the scientist, Robert Marcus Gunn who belongs to Scotland.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Presentation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pupil appears to dilate when light is shone on it (this is also known as a relative afferent pupillary defect or RAPD).</span></li><li><span style=\"font-size:12.0pt;\">The affected pupil constricts less than the unaffected pupil when light is shone on it.</span></li><li><span style=\"font-size:12.0pt;\">The affected pupil may even dilate when light is removed from it (this is known as the Marcus Gunn pupil phenomenon).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Diagnosed by a relative afferent pupillary defect (RAPD) test, also called swinging flash light test, which involves comparing the pupillary response of the affected eye to that of the unaffected eye when a light is shone on them.</span></li><li><span style=\"font-size:12.0pt;\">In the&nbsp;swinging flashlight test, a light is alternately shone into the left and right eyes. A normal response would be equal constriction of both pupils, regardless of which eye the light is directed at. This indicates an intact direct and consensual&nbsp;pupillary light reflex. When the test is performed in an eye with an afferent pupillary defect, light directed in the affected eye will cause only mild constriction of both pupils (due to decreased response to light from the afferent defect), while light in the unaffected eye will cause a normal constriction of both pupils (due to an intact efferent path, and an intact consensual pupillary reflex). Thus, light shone in the affected eye will produce less pupillary constriction than light shone in the unaffected eye.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Treatment involves addressing the underlying cause of the afferent pupillary defect, such as optic neuritis or a retinal detachment.</span></li><li><span style=\"font-size:12.0pt;\">In cases where the underlying cause cannot be treated, the patient may need to wear an eye patch to alleviate symptoms caused by the unequal pupillary responses.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-317.jpg\" alt=\"\" width=\"300\" height=\"359\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is called Argyl Robertson pupil:</strong> Incorrect, as Argyl Robertson pupils are associated with neurosyphilis and react to accommodation but not to light.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Both eyes are abnormal:</strong> Incorrect, the image specifically shows an abnormal reaction in one eye compared to a normal reaction in the other.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The vision is normal in the right eye:</strong> Incorrect as it is not specifically addressed in the image or scenario provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Marcus Gunn pupil, indicative of an RAPD, is a significant sign of optic nerve dysfunction often seen in conditions like optic neuritis. Detecting this early through the swinging flashlight test can guide further diagnostic and therapeutic interventions.</span></p>",
      "correct_choice_id": 52189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5877,
      "choices": [
        {
          "id": 23478,
          "text": "<p><span style=\"font-size:12pt;\">4 ml Mgso4 (50% w/v) in 16 ml NS</span></p>"
        },
        {
          "id": 23479,
          "text": "<p><span style=\"font-size:12pt;\">8 ml MgSo4 (50% w/v) in 12 ml NS</span></p>"
        },
        {
          "id": 23480,
          "text": "<p><span style=\"font-size:12pt;\">12 ml MgSo4 (50% w/v) in 8 ml NS</span></p>"
        },
        {
          "id": 23481,
          "text": "<p><span style=\"font-size:12pt;\">10 ml MgSO4 (50% w/v)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The loading dose of MgSo4 in pre-eclampsia is?&nbsp;</span>(INICET NOV 2019)</p>",
      "unique_key": "Q7349135",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601336,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 8 ml MgSo4 (50% w/v) in 12 ml NS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The drug of choice for the management of eclampsia is Magnesium Sulfate (MgSO4). The most commonly used regimen in India is the Pritchard regimen, which involves an initial loading dose followed by maintenance doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For the loading dose, the Pritchard regimen recommends:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Loading dose:</strong> 4 grams of MgSO4 as a 20% solution administered intravenously at 1 gram per minute.</span></li><li><span style=\"font-size:12pt;\">Additionally, 10 grams of 50% MgSO4 is administered intramuscularly, with 5 grams in each buttock.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this question, option B, \"8 ml MgSO4 (50% w/v) in 12 ml NS,\" correctly refers to the preparation required to administer the initial dose of MgSO4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The preparation details:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">MgSO4 is available in 50% and 20% concentrations.</span></li><li><span style=\"font-size:12pt;\">To make a 50% MgSO4 solution into a 20% solution, a 1.5 times dilution is required.</span></li><li><span style=\"font-size:12pt;\">For a 50% MgSO4 solution, 1 ml of the solution contains 0.5 grams of MgSO4 (1 ampoule = 2 ml).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The loading dose of MgSO4 in pre-eclampsia, as per the Pritchard regimen, is 4 grams of MgSO4 as a 20% solution administered intravenously, often prepared using 8 ml of 50% MgSO4 diluted in 12 ml normal saline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg273, Williams textbook of obstetrics 24<sup>th</sup> edition pg 1840</strong></span></p>",
      "correct_choice_id": 23479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11787,
      "choices": [
        {
          "id": 47114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased GFR </span></span></span></span></p>"
        },
        {
          "id": 47115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased creatinine </span></span></span></span></p>"
        },
        {
          "id": 47116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia </span></span></span></span></p>"
        },
        {
          "id": 47117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proteinuria</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is the most severe manifestation of CKD? (INICET NOV 2020)</span></span></span></span></p>",
      "unique_key": "Q2124079",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601337,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hyperkalemia&nbsp; </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia, characterized by elevated potassium levels in the blood, is particularly dangerous in CKD due to its direct impact on cardiac function. High potassium levels can disrupt normal heart rhythms, potentially leading to life-threatening cardiac arrhythmias.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased GFR</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it indicates the progression of CKD and reduced kidney function, it does not pose immediate life-threatening risks like hyperkalemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased creatinine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Indicates kidney dysfunction but is a marker rather than a direct cause of severe clinical consequences.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Proteinuria</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Signifies kidney damage; however, it is more of a prognostic indicator rather than an acute life-threatening condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia in CKD patients is a critical condition that requires immediate medical attention due to its potential to cause fatal cardiac disturbances. Always prioritize the management of hyperkalemia in CKD patients to prevent cardiac complications.</span></span></span></span></p>",
      "correct_choice_id": 47116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57699,
      "choices": [
        {
          "id": 230165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Risk of hypotension</span></span></span></p>"
        },
        {
          "id": 230166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Increased risk of liver toxicity</span></span></span></p>"
        },
        {
          "id": 230167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Potential to cause hyperglycemia</span></span></span></p>"
        },
        {
          "id": 230168,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk of severe muscle cramps</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 45-year-old woman with a history of hypertriglyceridemia is being considered for niacin therapy to help control her lipid levels. She also has well-controlled type 2 diabetes, managed with metformin and lifestyle modifications. Given her diabetic status, her physician is concerned about potential side effects associated with niacin use. Why should niacin be used with caution in this patient?</span></span></span></p>",
      "unique_key": "Q7876253",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601338,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Potential to cause hyperglycemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Niacin therapy, while effective in lowering triglycerides and improving lipid profiles, is associated with a risk of increasing blood glucose levels. Niacin can induce insulin resistance and reduce glucose-stimulated insulin secretion, potentially leading to hyperglycemia. This effect is particularly concerning in patients with diabetes, even those with well-controlled blood sugar levels. Therefore, niacin should be used cautiously in diabetic patients, and their blood glucose should be monitored closely, especially in the initial weeks of therapy to ensure that blood sugar levels remain within a safe range.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Risk of hypotension:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Niacin does not typically cause hypotension. It can cause vasodilation and flushing but does not significantly lower blood pressure to a concerning degree, especially not enough to be the primary caution in diabetic patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Increased risk of liver toxicity:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Although niacin can cause hepatotoxicity, particularly at high doses, this effect is not specific to diabetic patients and does not directly impact glucose control. Liver function should still be monitored, but it is not the primary concern when considering niacin in a diabetic patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Risk of severe muscle cramps:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Muscle cramps are more commonly associated with statin use rather than niacin. Niacin does not directly contribute to myopathy or muscle cramps and thus is not a specific concern in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Niacin can cause an increase in blood sugar levels due to insulin resistance and reduced glucose-stimulated insulin secretion, making its use risky in diabetic patients. Caution and close monitoring of blood glucose levels are necessary when prescribing niacin to individuals with diabetes, particularly those who have well-controlled blood sugar levels, to prevent hyperglycemia and ensure safe therapy.</span></span></span></p>",
      "correct_choice_id": 230167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13794,
      "choices": [
        {
          "id": 55137,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyaline cartilage</span></p>"
        },
        {
          "id": 55138,
          "text": "<p><span style=\"font-size:12.0pt;\">Elastic cartilage</span></p>"
        },
        {
          "id": 55139,
          "text": "<p><span style=\"font-size:12.0pt;\">Articular cartilage</span></p>"
        },
        {
          "id": 55140,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrocartilage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of cartilage shown in the image below:(NEET PG 2020)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-893.jpg\" alt=\"\" width=\"300\" height=\"225\"></p>",
      "unique_key": "Q4769558",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601459,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Elastic cartilage</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This image displays a type of cartilage called elastic cartilage.</span></li><li><span style=\"font-size:12.0pt;\">These elastic fibers give the cartilage its unique properties of flexibility and resilience, allowing it to easily return to its original shape after being bent or compressed.</span></li><li><span style=\"font-size:12.0pt;\">On microscopy, elastic cartilage consists of:</span><ul><li><span style=\"font-size:12.0pt;\">Chondrocytes within lacunae</span></li><li><span style=\"font-size:12.0pt;\">Elastic fibres in the matrix</span></li><li><span style=\"font-size:12.0pt;\">Perichondrium with outer fibrous layer and the inner cellular layer</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Maintains the shape of certain structures while allowing great flexibility.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Found in the ear (auricle or pinna), epiglottis, and eustachian tubes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyaline Cartilage</strong>: This is the most common type of cartilage. It appears glassy and smooth under the microscope. The extracellular matrix contains a large amount of type II collagen and is filled with chondrocytes, the cells responsible for cartilage synthesis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Provides smooth surfaces for movement at joints, flexibility, and support.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Found on joint surfaces, the rib tips, sternum, nose, trachea, and larynx.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Articular Cartilage</strong>: A type of hyaline cartilage that covers the surfaces of bones at synovial joints. It has a smooth, slippery surface that decreases friction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Enables bones of a synovial joint to slide over each other with minimal friction, distributes load in the joint, and allows for shock absorption.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Covers the ends of bones in all movable joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fibrocartilage</strong>: This is a tough, dense, and fibrous material that contains a mix of hyaline cartilage and dense collagen fibers.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Provides rigidity and shock absorption where it's needed, such as in areas of frequent pressure and pulling.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Found in intervertebral discs, pubic symphysis, menisci of the knee, and the points where tendons attach to bones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/07/screenshot-2023-11-07-183118.jpg\" alt=\"\" width=\"1000\" height=\"487\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-895_xnzdQMS.jpg\" alt=\"\" width=\"700\" height=\"432\"></p>",
      "correct_choice_id": 55138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13725,
      "choices": [
        {
          "id": 54861,
          "text": "<p><span style=\"font-size:12.0pt;\">Neer classification grade 4</span></p>"
        },
        {
          "id": 54862,
          "text": "<p><span style=\"font-size:12.0pt;\">Ideberg classification grade 4</span></p>"
        },
        {
          "id": 54863,
          "text": "<p><span style=\"font-size:12.0pt;\">Garden classification grade 3</span></p>"
        },
        {
          "id": 54864,
          "text": "<p><span style=\"font-size:12.0pt;\">Schatzker classification grade 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the type of fracture shown in the X-ray of left shoulder? (</span>AIIMS Nov 2017)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-622.jpg\" alt=\"\" width=\"254\" height=\"301\"></p>",
      "unique_key": "Q7487754",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601460,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Neer classification grade 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IMPORTANT CLASSIFICATIONS OF VARIOUS FRACTURES</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/screenshot-2024-02-07-145054.jpg\" alt=\"\" width=\"1000\" height=\"889\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>NEER CLASSIFICATION OF PROXIMAL HUMERUS FRACTURE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The classification consists of four major groupings, based on the number of displaced parts.</span></li><li><span style=\"font-size:12.0pt;\">One-part fracture:</span><ul><li><span style=\"font-size:12.0pt;\">Fracture lines involves 1 to 4 parts</span></li><li><span style=\"font-size:12.0pt;\">No or minimal displacement (i.e. &lt;1 cm and<strong>&nbsp;</strong>&lt;45°)</span></li><li><span style=\"font-size:12.0pt;\">Account for ~70-80% of all proximal humeral fractures and are almost always treated conservatively.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture11.jpg\" alt=\"\" width=\"300\" height=\"319\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Two-part fracture:</span><ul><li><span style=\"font-size:12.0pt;\">Fracture lines involves 2 to 4 parts</span></li><li><span style=\"font-size:12.0pt;\">One part is displaced (i.e. &gt;1 cm or &gt;45°)</span></li><li><span style=\"font-size:12.0pt;\">Four possible types of two-part fractures are:&nbsp;</span><ol><li><span style=\"font-size:12.0pt;\">Surgical neck: most common</span></li><li><span style=\"font-size:12.0pt;\">Greater tuberosity</span><ul><li><span style=\"font-size:12.0pt;\">Frequently seen in anterior shoulder dislocation</span></li><li><span style=\"font-size:12.0pt;\">A lower threshold of displacement (&gt;5 mm)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Anatomical neck</span></li><li><span style=\"font-size:12.0pt;\">Lesser tuberosity: uncommon</span></li></ol></li><li><span style=\"font-size:12.0pt;\">These fractures account for approximately 20% of proximal humeral fractures.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture12.jpg\" alt=\"\" width=\"300\" height=\"259\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Three-part fracture:</span><ul><li><span style=\"font-size:12.0pt;\">Fracture lines involves 3 or 4 parts</span></li><li><span style=\"font-size:12.0pt;\">Two parts are displaced (i.e. &gt;1 cm<strong>&nbsp;</strong>or &gt;45°)</span></li><li><span style=\"font-size:12.0pt;\">2 three-part fracture patterns are encountered:</span><ol><li><span style=\"font-size:12.0pt;\">Greater tuberosity and shaft are displaced with respect to the lesser tuberosity and articular surface which remain together – most common pattern</span></li><li><span style=\"font-size:12.0pt;\">Lesser tuberosity and shaft are displaced with respect to the greater tuberosity and articular surface which remain together</span></li></ol></li><li><span style=\"font-size:12.0pt;\">These fractures account for approximately 5% of proximal humeral fractures.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture13.jpg\" alt=\"\" width=\"300\" height=\"289\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Four-part fracture:</span><ul><li><span style=\"font-size:12.0pt;\">Fracture lines involves all 4 parts</span></li><li><span style=\"font-size:12.0pt;\">Three parts are displaced (i.e.&nbsp;&gt;1 cm or &gt;45°) with respect to the 4<sup>th</sup>.</span></li><li><span style=\"font-size:12.0pt;\">These fractures are uncommon (&lt;1% of proximal humeral fractures).</span></li><li><span style=\"font-size:12.0pt;\">This pattern has poor non-operative results as the articular surface is no longer attached to any parts of the humerus. This pattern has a high incidence of&nbsp;osteonecrosis. These fractures require operative management.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture14.jpg\" alt=\"\" width=\"300\" height=\"288\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ideberg classification grade 4.&nbsp;</strong>This system is used to classify the scapular fractures.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture15.jpg\" alt=\"\" width=\"600\" height=\"519\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture16.jpg\" alt=\"\" width=\"500\" height=\"219\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Garden classification grade 3</strong>. The&nbsp;<strong>Garden classification</strong>&nbsp;of&nbsp;subcapital femoral neck fractures&nbsp;is the most widely used. It predicts the development of&nbsp;osteonecrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/screenshot-2024-02-07-152246.jpg\" alt=\"\" width=\"1000\" height=\"424\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture17.jpg\" alt=\"\" width=\"500\" height=\"492\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Schatzker classification grade 5.</strong> This is used to classify tibial plateau fracture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture18.jpg\" alt=\"\" width=\"1000\" height=\"513\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image shows the grade 4 of the Neer’s classification of the proximal humerus fracture where all the fractured parts of the humerus are displaced.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture19.jpg\" alt=\"\" width=\"1000\" height=\"749\"></span></p>",
      "correct_choice_id": 54861,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7003,
      "choices": [
        {
          "id": 27980,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombin</span></span></span></p>"
        },
        {
          "id": 27981,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasmin</span></span></span></p>"
        },
        {
          "id": 27982,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antithrombin-III</span></span></span></p>"
        },
        {
          "id": 27983,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombomodulin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the action of heparin as an anticoagulant, availability of which of the following chemical substances is mandatory? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q7229827",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601461,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Antithrombin-III</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heparin acts indirectly by activating Antithrombin-III. The heparin-antithrombin III then binds to the clotting factors of the intrinsic pathway (10, 2, 9 ,11 and 12) and inactivates them. The anticoagulation action is exerted mainly by the inhibition of factor 10 as well as thrombin or factor 2. Therefore Antithrombin-Ill is mandatory for the action of heparin as an anticoagulant. Reduced antithrombin levels can lead to resistance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In true heparin resistance, there is an actual blunting of heparin&#39;s anticoagulant effect. This occurs due to:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low ATIII levels (most common cause)</span></span></span></li>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased heparin-binding plasma proteins (acute phase reactants)</span></span></span></li>\r\n\t<li><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased heparin clearance (e.g., due to splenomegaly in liver disease)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low ATIII levels could be due to decreased synthesis (hereditary, hepatic failure), increased consumption (DIC, MAHA, or in a bypass circuit) or increased loss (nephrotic syndrome).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The dose of heparin has to be increased to achieve therapeutic aPTT. Severe antithrombin deficiency may require antithrombin concentrate as well.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Thrombin is a target of the heparin-antithrombin III complex, not a necessary cofactor for heparin&#39;s action.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plasmin is involved in fibrinolysis (the breakdown of clots) and is not directly related to the anticoagulant action of heparin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombomodulin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Thrombomodulin is a receptor that binds thrombin and is involved in the activation of protein C, which has anticoagulant properties. However, it is not directly required for the action of heparin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The availability of antithrombin-III is mandatory for the anticoagulant action of heparin, as it forms a complex with heparin to inactivate key enzymes in the coagulation cascade.</span></span></span></p>",
      "correct_choice_id": 27982,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9854,
      "choices": [
        {
          "id": 39382,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 1</span></span></span></p>"
        },
        {
          "id": 39383,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 8</span></span></span></p>"
        },
        {
          "id": 39384,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 9</span></span></span></p>"
        },
        {
          "id": 39385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 4</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following caspase binds to Cytochrome C and APAF-1 complex? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q2212603",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601462,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) Caspase 9 </strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 9 binds to Cyt-c and APAF-1 complex.</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Apoptotic stimuli cause the release <em>of <strong>c</strong></em><strong>ytochrome C into the cytosol</strong>. Cytochrome-C binds to a protein called <strong>APAF-1 (apoptosis-activating factor-1)</strong> to form the apoptosome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">This complex then binds <strong>caspase-9,</strong> resulting in the activation of other caspases.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/984.jpg\" style=\"height:450px; width:630px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Caspase 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory response and not in the intrinsic apoptotic pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Caspase 8</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Associated with the extrinsic apoptotic pathway, activated by death receptors on the cell surface.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Caspase 4</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory response and not directly related to the intrinsic apoptotic pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase 9 is the initiator caspase in the intrinsic apoptotic pathway and is activated by binding to the cytochrome C and APAF-1 complex (the apoptosome).</span></span></span></p>",
      "correct_choice_id": 39384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14449,
      "choices": [
        {
          "id": 57757,
          "text": "<p><span style=\"font-size:12pt;\">Hartmann's operation is done in elderly debilitated patients</span></p>"
        },
        {
          "id": 57758,
          "text": "<p><span style=\"font-size:12pt;\">Adenocarcinoma is a rare variant of rectal carcinoma</span></p>"
        },
        {
          "id": 57759,
          "text": "<p><span style=\"font-size:12pt;\">Early morning spurious diarrhea and tenesmus can occur</span></p>"
        },
        {
          "id": 57760,
          "text": "<p><span style=\"font-size:12pt;\">Growth confined to the rectal mucosa is stage A of modified Duke's staging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the incorrect statement regarding rectal carcinoma? (</span>NEET PG 2019)</p>",
      "unique_key": "Q9311179",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601463,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Adenocarcinoma is a rare variant of rectal carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Adenocarcinoma is the most common variant of rectal carcinoma, accounting for over 95% of cases. This type of cancer originates from the glandular cells lining the rectum. Therefore, stating that adenocarcinoma is a rare variant is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hartmann's operation is done in elderly debilitated patients: </strong>This statement is true. Hartmann's operation is a surgical procedure often performed in elderly or debilitated patients with rectal carcinoma. The operation involves resection of the diseased segment of the colon, closure of the remaining rectal stump (forming a \"Hartmann's pouch\"), and creation of an end colostomy with the proximal colon. It is a suitable option for patients who may not tolerate a more extensive surgical procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Early morning spurious diarrhea and tenesmus can occur: </strong>This statement is true. Patients with rectal carcinoma commonly experience symptoms such as diarrhea and tenesmus (a sensation of incomplete evacuation after bowel movements). These symptoms can occur at any time of the day, including early morning, due to the irritation and obstruction caused by the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Growth confined to the rectal mucosa is stage A of modified Duke's staging: </strong>This statement is true. According to the modified Duke's staging system for colorectal cancer, stage A refers to cancer that is confined to the mucosa of the rectum. This early stage indicates that the tumor has not yet penetrated deeper layers or spread beyond the rectum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Adenocarcinoma is the most common type of rectal carcinoma, accounting for over 95% of cases, making it incorrect to describe it as a rare variant.</span></p>",
      "correct_choice_id": 57758,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6778,
      "choices": [
        {
          "id": 27081,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3</span></p>"
        },
        {
          "id": 27082,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4</span></p>"
        },
        {
          "id": 27083,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3</span></p>"
        },
        {
          "id": 27084,
          "text": "<p><span style=\"font-size:12.0pt;\">2,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Consider the following statements about sympathetic, parasympathetic, and motor nerves. Which of the following statements are true?&nbsp;</span>(INICET MAY 2022)</p><p>&nbsp;</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Sympathetic efferent are distributed all over the body/ extensively whereas parasympathetic distribution is limited.</span></li><li><span style=\"font-size:12.0pt;\">Sympathetic fibers travel long distances after leaving the sympathetic chain, before finally synapsing and then a shorter distance to effector organs.</span></li><li><span style=\"font-size:12.0pt;\">Parasympathetic fibers travel a shorter distance to their respective ganglia which are located close to the target organs.</span></li><li><span style=\"font-size:12.0pt;\">Motor neurons are located in the ventral horn of the spinal cord from where the axons come out and divide into several branches, each of which supplies an individual muscle fiber.</span></li></ol><p>&nbsp;</p>",
      "unique_key": "Q6477879",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601464,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The true statements are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1. Sympathetic efferents are distributed all over the body extensively, whereas parasympathetic distribution is limited.</strong> Sympathetic fibers provide widespread distribution throughout the body, innervating various organs and tissues. In contrast, parasympathetic fibers have a more restricted distribution, primarily targeting the head, neck, and trunk regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4. Motor neurons are located in the ventral horn of the spinal cord from where the axons come out and divide into several branches, each of which supplies an individual muscle fiber.</strong> Motor neurons originate in the ventral horn of the spinal cord, and their axons branch out to innervate individual muscle fibers, facilitating voluntary muscle movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2:&nbsp;</strong>Incorrect. Sympathetic fibers do not travel long distances after leaving the sympathetic chain before synapsing. Instead, sympathetic preganglionic fibers travel a short distance to the ganglia (which are located close to the spinal cord) and then the postganglionic fibers travel a long distance to reach the effector organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3:&nbsp;</strong>Incorrect. Parasympathetic fibers travel a long distance to their respective ganglia which are located close to or within the target organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sympathetic efferent are distributed all over the body/ extensively whereas parasympathetic distribution is limited to head neck and trunk</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-122430.png\" alt=\"\" width=\"800\" height=\"734\"></span></p>",
      "correct_choice_id": 27082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57700,
      "choices": [
        {
          "id": 230169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Pyruvate Carboxylase</span></span></span></p>"
        },
        {
          "id": 230170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Phosphofructokinase-1</span></span></span></p>"
        },
        {
          "id": 230171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Hexokinase</span></span></span></p>"
        },
        {
          "id": 230172,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 45-year-old woman with a history of prolonged fasting is admitted to the hospital with fatigue and dizziness. Laboratory tests reveal low blood glucose levels, despite her attempts to consume protein-rich food. The medical team suspects a metabolic disorder affecting glucose synthesis. Which enzyme plays a crucial role in the patient&#39;s ability to produce glucose during fasting?</span></span></span></p>",
      "unique_key": "Q2135546",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601465,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A. Pyruvate Carboxylase</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Pyruvate Carboxylase is a key enzyme in gluconeogenesis that catalyzes the conversion of pyruvate to oxaloacetate. This reaction is essential for gluconeogenesis, which allows the body to generate glucose from non-carbohydrate substrates such as amino acids and lactate during fasting or starvation. The enzyme plays a critical role in bypassing the irreversible steps of glycolysis, permitting glucose synthesis when dietary intake is low.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Phosphofructokinase-1:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This enzyme is primarily involved in glycolysis, not gluconeogenesis. It converts fructose-6-phosphate to fructose-1,6-bisphosphate, playing a regulatory role in glycolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Hexokinase:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Hexokinase is involved in the glycolytic pathway and catalyzes the phosphorylation of glucose to glucose-6-phosphate. It does not function in gluconeogenesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Glucokinase:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Similar to hexokinase, glucokinase is involved in glycolysis, especially in the liver, converting glucose to glucose-6-phosphate. It is not part of the gluconeogenic pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluconeogenesis is critical for maintaining blood glucose levels during periods of fasting. Key enzymes like pyruvate carboxylase facilitate the conversion of non-carbohydrate sources into glucose, enabling the body to sustain energy levels when dietary glucose is unavailable.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/picture1_46preXi.jpg\" style=\"height:1269px; width:1000px\" /></span></span></p>",
      "correct_choice_id": 230169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10049,
      "choices": [
        {
          "id": 40162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alkaline hematin</span></span></span></p>"
        },
        {
          "id": 40163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid hematin</span></span></span></p>"
        },
        {
          "id": 40164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oxyhemoglobin</span></span></span></p>"
        },
        {
          "id": 40165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deoxyhemoglobin</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The instrument shown below is used for estimating for hemoglobin levels. What does it measure? (INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/51_BqIE09s.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8498984",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601486,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Acid hematin</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The instrument shown in the image is a <strong>Sahli&rsquo;s Hemoglobinometer</strong>, which is used to estimate hemoglobin levels in the blood. The principle of this method is based on the conversion of hemoglobin into acid hematin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PRINCIPLE OF SAHLI&rsquo;S HEMOGLOBINOMETER</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood is mixed with an acid solution so that hemoglobin is converted to brown-colored acid hematin. This is then diluted with water till the brown color matches that of the brown glass standard. The hemoglobin value is read directly from the scale.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture13.jpg\" style=\"height:281px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sahli&rsquo;s Hemoglobinometer estimates hemoglobin levels by converting hemoglobin into acid hematin, which is then compared to a color standard.</span></span></span></p>",
      "correct_choice_id": 40163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5225,
      "choices": [
        {
          "id": 20872,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior laryngeal nerve injury</span></p>"
        },
        {
          "id": 20873,
          "text": "<p><span style=\"font-size:12.0pt;\">Unilateral recurrent laryngeal nerve injury</span></p>"
        },
        {
          "id": 20874,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral recurrent laryngeal nerve injury</span></p>"
        },
        {
          "id": 20875,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following total thyroidectomy, a patient started having difficulty in breathing, and repeated attempts to extubate were unsuccessful. The most probable cause is: (NEET PG 2021)</span></p>",
      "unique_key": "Q5470338",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601487,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Bilateral recurrent laryngeal nerve injury</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical picture is suggestive of bilateral recurrent laryngeal nerve injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bilateral recurrent laryngeal injury is commonly seen in total thyroidectomy.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Injury to both RLNs results in paralysis of intrinsic muscles of the larynx. The vocal cords cannot be abducted and thus come to lie in a median or paramedian position due to unopposed action of cricothyroid. This results in compromised laryngeal airway causing respiratory distress and stridor.</span></li><li><span style=\"font-size:12.0pt;\">Tracheostomy is done as an emergency procedure to secure the airway.</span></li><li><span style=\"font-size:12.0pt;\">Widening the respiratory airway without a permanent tracheostomy can be achieved by:</span><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Transverse cordotomy (Kashima operation)</span></li><li><span style=\"font-size:12.0pt;\">Partial arytenoidectomy</span></li><li><span style=\"font-size:12.0pt;\">Reinnervation procedures - these are used to innervate paralyzed posterior cricoarytenoid muscle by implanting a nerve-muscle pedicle of sternohyoid or omohyoid muscle with its nerve supply from ansa hypoglossi.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;Thyroplasty type II – lateralisation of vocal cords</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Superior laryngeal nerve injury</strong> - This would primarily affect voice pitch and not typically cause significant breathing difficulty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Unilateral recurrent laryngeal nerve injury</strong> - Would lead to hoarseness but not usually severe breathing issues as one vocal cord would still function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Hematoma</strong> - Although it can cause acute respiratory distress if it compresses the trachea, it does not typically lead to issues with extubation unless it is very severe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Bilateral recurrent laryngeal nerve injury after thyroidectomy is a serious complication that can lead to life-threatening airway obstruction. Immediate recognition and management are crucial to ensure the safety and recovery of the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 339</strong></span></p>",
      "correct_choice_id": 20874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11103,
      "choices": [
        {
          "id": 44378,
          "text": "<p><span style=\"font-size:18px;\">Bar diagram, dot plot</span></p>"
        },
        {
          "id": 44379,
          "text": "<p><span style=\"font-size:18px;\">Line diagram, dot plot</span></p>"
        },
        {
          "id": 44380,
          "text": "<p><span style=\"font-size:18px;\">Histogram, dot plot</span></p>"
        },
        {
          "id": 44381,
          "text": "<p><span style=\"font-size:18px;\">Pie chart, dot plot</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A laboratory technician is analyzing cell populations using flow cytometry. This technique allows for the simultaneous multiparametric analysis of the physical and/or chemical characteristics of single cells flowing through an optical and/or electronic detection apparatus. Which visual depictions are commonly generated in flow cytometry for the evaluation of these cell populations? [</strong><i><strong>INICET MAY 2021]</strong></i></span></p>",
      "unique_key": "Q3458668",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601488,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Histogram, dot plot</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Histogram and Dot plot can be used to depict flow cytometry analysis.</span></li><li><span style=\"font-size:18px;\">Histogram can be used to compare single parameter (1D)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture4777.jpg\" alt=\"\" width=\"700\" height=\"215\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">&nbsp;Scatter/Dot plot are used to compare 2 or 3 parameters (2D; 3D)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture5555.jpg\" alt=\"\" width=\"700\" height=\"217\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Flow Cytometry is used to detect and measure physical and chemical characteristics of a population of cells or parameters like cell counting, sorting, detect microorganisms, detect neoplasm and various more.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In flow cytometry, histograms and dot plots are the common visual depictions for evaluating cell populations.</span></li></ul>",
      "correct_choice_id": 44380,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11730,
      "choices": [
        {
          "id": 46886,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></span></span></span></p>"
        },
        {
          "id": 46887,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloroquine</span></span></span></span></p>"
        },
        {
          "id": 46888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxychloroquine</span></span></span></span></p>"
        },
        {
          "id": 46889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketoconazole</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is used in the treatment of hypercalcemia due to Vitamin D toxicity?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Aptos&quot;,sans-serif\"> (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q3907651",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601489,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone is utilized in the treatment of hypercalcemia, particularly when induced by Vitamin D toxicity. This corticosteroid helps reduce calcium absorption from the intestine and increase calcium excretion, effectively lowering serum calcium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Chloroquine:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used primarily as an antimalarial and in autoimmune diseases, it does not play a role in managing hypercalcemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hydroxychloroquine:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to chloroquine, used for autoimmune disorders but not for hypercalcemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ketoconazole:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An antifungal medication that can reduce corticosteroid production but is not specifically used to treat hypercalcemia caused by Vitamin D toxicity</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone, Bisphosphonates, IV fluids, Loop diuretics, Calcitonin are used in the management of Hypercalcemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - (Harrison/Endocrinology/Hypercalcemia)</span></span></strong></span></span></p>",
      "correct_choice_id": 46886,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57701,
      "choices": [
        {
          "id": 230173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Competitive Inhibition</span></span></span></p>"
        },
        {
          "id": 230174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Non-competitive Inhibition</span></span></span></p>"
        },
        {
          "id": 230175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Michaelis-Menten Kinetics</span></span></span></p>"
        },
        {
          "id": 230176,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allosteric Regulation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 35-year-old male with a background of metabolic research is studying an enzyme-catalyzed reaction in his laboratory. He plots the reaction velocity against substrate concentration and observes the curve shown in the graph below. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/picture2_uTNDNtM.jpg\" style=\"height:240px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">What type of kinetic pattern is most likely being depicted in the graph?</span></span></span></p>",
      "unique_key": "Q5473574",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601490,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Michaelis-Menten Kinetics</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The graph depicts a classic Michaelis-Menten kinetic pattern characterized by a hyperbolic relationship between reaction velocity and substrate concentration. Michaelis-Menten kinetics describes enzyme activity where the reaction velocity increases with substrate concentration but eventually plateaus as the enzyme becomes saturated with substrate. The key points of Michaelis-Menten kinetics include Vmax, the maximum reaction velocity when the enzyme is fully saturated, and Km, the substrate concentration at which the reaction velocity is half of Vmax. This kinetic model is typical for enzymes that follow simple substrate binding and catalysis without significant allosteric or cooperative interactions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Competitive Inhibition:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> In competitive inhibition, an inhibitor competes with the substrate for the active site of the enzyme, which can be overcome by increasing substrate concentration. The graph of competitive inhibition would show an increase in Km without altering Vmax, which differs from the hyperbolic curve seen in Michaelis-Menten kinetics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Non-competitive Inhibition:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Non-competitive inhibition occurs when an inhibitor binds to an enzyme at a site other than the active site, reducing the overall number of active enzymes. This type of inhibition lowers Vmax without affecting Km, resulting in a different pattern from the Michaelis-Menten kinetics shown in the graph.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Allosteric Regulation:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Allosteric enzymes exhibit sigmoidal curves rather than hyperbolic curves due to cooperative substrate binding. These enzymes are regulated by effectors that alter their activity, making their kinetics distinct from the Michaelis-Menten kinetics depicted in the graph.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Michaelis-Menten kinetics describes enzyme behavior where reaction velocity increases with substrate concentration but reaches a plateau at high substrate levels due to enzyme saturation. Key features include Vmax and Km, which help determine the efficiency and affinity of enzyme-substrate interactions.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/picture3.jpg\" style=\"height:449px; width:700px\" /></span></span></p>",
      "correct_choice_id": 230175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5909,
      "choices": [
        {
          "id": 23606,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        },
        {
          "id": 23607,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myomectomy</span></span></span></p>"
        },
        {
          "id": 23608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No intervention as the patient is asymptomatic</span></span></span></p>"
        },
        {
          "id": 23609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical management</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman is found to have a fibroid of 14 weeks size. She has no specific symptoms. What is the next step in management?&nbsp;</span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q8734014",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601531,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) No intervention as the patient is asymptomatic</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of an asymptomatic fibroid, intervention is generally not required regardless of the size. The management approach is typically conservative, involving observation and regular monitoring.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic Fibroids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fibroids that do not cause symptoms do not require immediate intervention. Instead, they can be observed with yearly ultrasounds or reviewed earlier if symptoms develop.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common Symptoms of Fibroids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These include heavy menstrual bleeding, dysmenorrhea, pressure symptoms, and the presence of an abdominal mass.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of Symptomatic Fibroids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Depending on the patient&#39;s age, size of the fibroid, number, and location, symptomatic fibroids may be considered for myomectomy or hysterectomy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a major surgical procedure and is typically reserved for symptomatic fibroids or when other treatment options have failed or are not suitable.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Myomectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Myomectomy is a surgical procedure to remove fibroids and is considered for symptomatic patients who wish to preserve their uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Medical management:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Medical management is used to manage symptoms and is not necessary for asymptomatic fibroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In asymptomatic patients with fibroids, intervention is generally not required. Observation and regular monitoring are appropriate unless symptoms develop, in which case, further management options such as myomectomy or hysterectomy may be considered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Williams Textbook of gynecology 3<sup>rd</sup>edition Pg207</span></strong></span></span></p>",
      "correct_choice_id": 23608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6496,
      "choices": [
        {
          "id": 25953,
          "text": "<p><span style=\"font-size:12.0pt;\">5-Fluorouracil</span></p>"
        },
        {
          "id": 25954,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 25955,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitrofurantoin</span></p>"
        },
        {
          "id": 25956,
          "text": "<p><span style=\"font-size:12.0pt;\">Novobiocin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an inhibitor of RNA synthesis? (NEET PG 2020)</span></p>",
      "unique_key": "Q9511102",
      "question_audio": null,
      "question_video": null,
      "map_id": 12601532,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rifampicin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Among the options mentioned above, Rifampicin is the drug that acts by blocking RNA polymerase enzyme. It is one of the 1<sup>st</sup> line Anti Tubercular and anti-Leprosy drugs. It has the bactericidal effect against the mycobacteria, that are present both intracellularly as well as extracellularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 5-Fluorouracil</strong>: This is an anticancer drug that primarily inhibits thymidylate synthase, affecting DNA synthesis rather than specifically inhibiting RNA synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nitrofurantoin</strong>: This drug is primarily used for treating urinary tract infections. It does inhibit bacterial DNA, RNA, and protein synthesis but is not specifically an inhibitor of RNA synthesis alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Novobiocin</strong>: This antibiotic inhibits DNA gyrase, an enzyme involved in DNA supercoiling, but it does not inhibit RNA synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-105712.png\" alt=\"\" width=\"1000\" height=\"309\"></p>",
      "correct_choice_id": 25954,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6066,
      "choices": [
        {
          "id": 24234,
          "text": "<p><span style=\"font-size:12pt;\">Early-onset preeclampsia</span></p>"
        },
        {
          "id": 24235,
          "text": "<p><span style=\"font-size:12pt;\">Late-onset preeclampsia</span></p>"
        },
        {
          "id": 24236,
          "text": "<p><span style=\"font-size:12pt;\">Fetal growth restriction</span></p>"
        },
        {
          "id": 24237,
          "text": "<p><span style=\"font-size:12pt;\">Placenta accreta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with an obstetric score of G2P1 comes to the clinic at 14 weeks of gestation for her antenatal checkup. A uterine artery doppler was suggested by the doctor. What would it detect?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q1721204",
      "question_audio": null,
      "question_video": null,
      "map_id": 12782260,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Early-onset preeclampsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Early-onset preeclampsia:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Uterine artery Doppler at 11-14 weeks of gestation can detect markers predictive of early-onset preeclampsia.</span></li><li><span style=\"font-size:12pt;\">Raised pulsatility index (PI) in the uterine artery and notching of the uterine artery waveform are indicative markers.</span></li><li><span style=\"font-size:12pt;\">Biochemical markers for early-onset preeclampsia include decreased levels of PP13, VEGF, PAPPA, and PlGF, and increased levels of sFlt-1, sEng, and cell-free DNA.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Predictors of Preeclampsia:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>History and Mean Arterial Pressure (MAP):</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">A patient's medical history and MAP are initial predictors.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Biophysical Markers:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Uterine artery Doppler: Raised PI and notching of the waveform are early indicators.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Biochemical Markers:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Decreased: PP13, VEGF, PAPPA, PlGF.</span></li><li><span style=\"font-size:12pt;\">Increased: sFlt-1, sEng, cell-free DNA.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Anti-angiogenic Factors:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">sFlt-1 and sEng are important markers indicating anti-angiogenic activity, which is associated with preeclampsia.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Late-onset preeclampsia:&nbsp;</strong>Uterine artery Doppler is more predictive of early-onset rather than late-onset preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Fetal growth restriction:&nbsp;</strong>While fetal growth restriction can be associated with preeclampsia, the uterine artery Doppler specifically predicts early-onset preeclampsia rather than fetal growth restriction alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Placenta accreta:&nbsp;</strong>Uterine artery Doppler is not used to detect placenta accreta. Placenta accreta is typically diagnosed through ultrasound or MRI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A uterine artery Doppler at 11-14 weeks gestation can predict early-onset preeclampsia by identifying raised pulsatility index (PI) and notching of the uterine artery waveform.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1818, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6024,
      "choices": [
        {
          "id": 24066,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary syphilis</span></span></span></p>"
        },
        {
          "id": 24067,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital syphilis</span></span></span></p>"
        },
        {
          "id": 24068,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary syphilis</span></span></span></p>"
        },
        {
          "id": 24069,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latent syphilis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kassowitz rule is related to?&nbsp;</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q7438783",
      "question_audio": null,
      "question_video": null,
      "map_id": 12782261,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Congenital syphilis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kassowitz&#39;s rule pertains to congenital syphilis. According to this rule, if a woman with untreated syphilis has multiple pregnancies, the likelihood of congenital syphilis affecting the fetus in later pregnancies decreases. This phenomenon is observed as a result of the immune system&#39;s adaptive response and potential changes in the transmission dynamics of the infection over successive pregnancies. Therefore, the rule suggests that with each subsequent pregnancy, the outcome for the fetus improves if the infection remains untreated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Primary syphilis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Primary syphilis involves the initial chancre or ulcer at the site of infection and is not related to Kassowitz&#39;s rule, which specifically addresses outcomes in congenital syphilis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Secondary syphilis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Secondary syphilis is characterized by systemic manifestations such as skin rashes and mucous membrane lesions and is not related to Kassowitz&#39;s rule.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Latent syphilis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Latent syphilis refers to a stage where no symptoms are present but the infection is still systemic. Kassowitz&#39;s rule is not associated with latent syphilis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kassowitz rule states that the likelihood of congenital syphilis infection decreases with each successive pregnancy in a woman with untreated syphilis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 343, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11327,
      "choices": [
        {
          "id": 45274,
          "text": "<p><span style=\"font-size:12.0pt;\">Add intravenous enalaprilat</span></p>"
        },
        {
          "id": 45275,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase nitroprusside infusion</span></p>"
        },
        {
          "id": 45276,
          "text": "<p><span style=\"font-size:12.0pt;\">Repair the descending aorta</span></p>"
        },
        {
          "id": 45277,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch nitroprusside to amlodipine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman with a recent type B aortic dissection presents with abdominal pain and lower limb ischemia with diminished femoral and popliteal pulses. What is the most appropriate next step?</span></p>",
      "unique_key": "Q2369929",
      "question_audio": null,
      "question_video": null,
      "map_id": 12782262,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Repair the descending aorta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">New-onset abdominal pain and limb ischemia in a patient with type B aortic dissection indicate a complicated dissection, likely due to malperfusion of the mesenteric and lower extremity arteries. This requires urgent surgical or endovascular repair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Enalaprilat:</strong> Although used for blood pressure control, it doesn't address the underlying issue of malperfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increasing nitroprusside:</strong> May help with blood pressure control but doesn't solve the urgent need for revascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. &nbsp;Switching to amlodipine:</strong> Not appropriate in an acute setting requiring immediate intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the signs of complicated type B aortic dissection (malperfusion syndromes) and the need for immediate surgical/endovascular repair.</span></p>",
      "correct_choice_id": 45276,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54764,
      "choices": [
        {
          "id": 218521,
          "text": "<p><span style=\"font-size:18px;\">Only CD4 contributed to graft rejection significantly</span></p>"
        },
        {
          "id": 218522,
          "text": "<p><span style=\"font-size:18px;\">Only CD8 contributed to graft rejection significantly</span></p>"
        },
        {
          "id": 218523,
          "text": "<p><span style=\"font-size:18px;\">Both CD4 and CD8 protected against graft rejection significantly</span></p>"
        },
        {
          "id": 218524,
          "text": "<p><span style=\"font-size:18px;\">Both CD4 and CD8 contributed to graft rejection significantly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>For the given Kaplan-Meier curve on the role of T-cells in the allograft rejection process, true statement is:&nbsp;[</strong><i><strong>INICET MAY 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/untitled-222.jpg\" alt=\"\" width=\"400\" height=\"161\"></strong></span></p>",
      "unique_key": "Q2063059",
      "question_audio": null,
      "question_video": null,
      "map_id": 12782263,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Both CD4 and CD8 contributed to graft rejection significantly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Kaplan-Meier curve presented in this question shows the survival rates of grafts in mice after they were treated with monoclonal antibodies designed to deplete specific T-cells (CD4 and CD8). The survival curves illustrate how the presence or absence of these T-cells affects graft rejection.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Anti-CD8 Group (Pink Line):&nbsp;</strong>The curve for mice treated with anti-CD8 antibodies (which deplete CD8 T-cells) shows a survival rate very similar to the control group. This indicates that the removal of CD8 T-cells alone does not significantly affect graft survival.</span></li><li><span style=\"font-size:18px;\"><strong>Anti-CD4 Group (Blue Line):&nbsp;</strong>The curve for the anti-CD4 group shows an extended graft survival compared to the control and anti-CD8 groups. This indicates that CD4 T-cells play a more significant role in graft rejection than CD8 T-cells alone. Removal of CD4 prolongs survival from 15 to 30 days.</span></li><li><span style=\"font-size:18px;\"><strong>Anti-CD4 + Anti-CD8 Group (Green Line):&nbsp;</strong>The green curve represents mice treated with both anti-CD4 and anti-CD8 antibodies. This group shows the longest survival of grafts, extending up to 60 days. The combination of depleting both CD4 and CD8 T-cells significantly delays graft rejection, demonstrating that both types of T-cells are involved in the rejection process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">The conclusion drawn from this curve is that both CD4 and CD8 T-cells contribute to graft rejection, and their combined effect is more pronounced than the effect of either cell type alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Both CD4 and CD8 T-cells are crucial contributors to the allograft rejection process, and their combined depletion significantly prolongs graft survival.</span></p>",
      "correct_choice_id": 218524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}